Filed Pursuant to Rule 424(b)(5)
Registration No. 333-203622
Prospectus Supplement
(To Prospectus dated April 24, 2015)
ENERGOUS CORPORATION
Common
Stock
Having
an Aggregate Offering Price of Up to
$40,000,000
We have entered into a distribution
agreement with Raymond James & Associates, Inc., as our sales agent, relating to the shares of common stock of Energous
Corporation, par value $0.00001, offered by this prospectus supplement. In accordance with the terms of the distribution agreement,
we may offer and sell shares of common stock having an aggregate offering price of up to $40,000,000 from time to time through
or to our sales agent.
Sales of common stock under this prospectus
supplement, if any, will be made by means of ordinary brokers’ transactions through the facilities of The Nasdaq Stock Market,
any other national securities exchange or facility thereof, a trading facility of a national securities association or an alternate
trading system, to or through a market maker or directly on or through an electronic communication network or any similar market
venue, at market prices, in block transactions or as otherwise agreed between us and the sales agent. Our common stock trades on
The Nasdaq Stock Market under the symbol “WATT.” On January 11, 2018, the last reported sale price of our common stock
on The Nasdaq Stock Market was $23.02 per share.
The compensation of our sales agent
for sales of common stock shall be a commission rate equal to 2.5% of the gross sales price per share of common stock. The net
proceeds from any sales under this prospectus supplement will be used as described under “Use of Proceeds” in this
prospectus supplement.
Under the terms of the distribution
agreement, we also may sell common stock to the sales agent as principal for its own account at a price agreed upon at the time
of the sale. If we sell common stock to the sales agent as principal, we will enter into a separate terms agreement with the sales
agent, and the sale will be made pursuant to the terms thereunder.
The sales agent is not required to sell
any specific number or dollar amount of common stock but will use its commercially reasonable efforts, as our agent and subject
to the terms of the distribution agreement, to sell the common stock offered, as instructed by us. The offering of common stock
pursuant to the distribution agreement will terminate upon the earlier of (i) the sale of all common stock subject to the
distribution agreement or (ii) the termination of the distribution agreement by us or by the sales agent pursuant to the terms
of the distribution agreement.
We are an “emerging growth company”
as that term is used in the Jumpstart Our Business Startups Act of 2012 and, as such, have elected to comply with certain reduced
public company reporting requirements for this prospectus and future filings. See “Prospectus Supplement Summary—Implications
of Being an Emerging Growth Company.”
Investing in our common stock involves
a high degree of risk. Please read “Risk Factors” beginning on page S-6 of this prospectus supplement and the accompanying
prospectus and in the documents incorporated by reference into this prospectus supplement.
Neither the Securities and Exchange
Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus
supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
RAYMOND JAMES
The date of this prospectus supplement is
January 12, 2018.
Table
of Contents
About This
Prospectus Supplement
This prospectus supplement and the accompanying
prospectus form part of a registration statement on Form S-3 that we filed with the Securities and Exchange Commission, or the
SEC, using a “shelf” registration process. This document contains two parts. The first part consists of this prospectus
supplement, which provides you with specific information about this offering. The second part, the accompanying prospectus, provides
more general information, some of which may not apply to this offering. Generally, when we refer only to the “prospectus,”
we are referring to both parts combined. This prospectus supplement, and the information incorporated herein by reference, may
add, update or change information in the accompanying prospectus. You should read the entire prospectus supplement as well as the
accompanying prospectus and the documents incorporated by reference herein that are described under the headings “Where You
Can Find More Information” and “Incorporation of Certain Information by Reference.” If there is any inconsistency
between the information in this prospectus supplement and the accompanying prospectus, you should rely on the information in this
prospectus supplement.
You should rely only on the information
contained in or incorporated by reference into this prospectus supplement, the accompanying prospectus and any free writing prospectus
we may provide to you in connection with this offering. Neither we nor the sales agent have authorized any other person to provide
you with different information. If anyone provides you with different or inconsistent information, you should not rely on it.
The information appearing in this prospectus
supplement, the accompanying prospectus and any free writing prospectus we may provide to you in connection with this offering
is accurate only as of the date of the respective document and any information we have incorporated by reference is accurate only
as of the date of the document incorporated by reference, regardless of the time of delivery of this prospectus supplement, the
accompanying prospectus, any free writing prospectus we may provide to you in connection with this offering, or any sale of a security.
Our business, financial condition, results of operations and prospects may have changed since those dates. You should read this
prospectus supplement, the accompanying prospectus, any free writing prospectus prepared by us or on our behalf, and the documents
incorporated by reference in the prospectus supplement, in their entirety before making any investment decision.
We are offering to sell, and seeking offers
to buy, our securities only in jurisdictions where offers and sales are permitted. The distribution of this prospectus supplement
and the offering of the securities in certain jurisdictions may be restricted by law. Persons outside the United States who come
into possession of this prospectus supplement must inform themselves about, and observe any restrictions relating to, the offering
of the securities and the distribution of this prospectus supplement outside the United States. This prospectus supplement does
not constitute, and may not be used in connection with, an offer to sell, or a solicitation of an offer to buy, any securities
offered by this prospectus supplement by any person in any jurisdiction in which it is unlawful for such person to make such an
offer or solicitation.
The industry and market data and other statistical
information contained in this prospectus supplement, the accompanying prospectus and the documents we incorporate by reference
are based on management’s estimates, independent publications, government publications, reports by market research firms
or other published independent sources, and, in each case, are believed by management to be reasonable estimates. Although we believe
these sources are reliable, we have not independently verified the information. None of the independent industry publications used
in this prospectus supplement, the accompanying prospectus or the documents we incorporate by reference were prepared on our or
our affiliates’ behalf and none of the sources cited by us consented to the inclusion of any data from its reports, nor have
we sought their consent.
The representations, warranties and covenants
made by us in any agreement that is filed as an exhibit to any document that is incorporated by reference in this prospectus were
made solely for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating risk among
the parties to such agreements, and should not be deemed to be a representation, warranty or covenant to you. Moreover, such representations,
warranties or covenants were accurate only as of the date when made. Accordingly, such representations, warranties and covenants
should not be relied on as accurately representing the current state of our affairs.
In this prospectus supplement, unless otherwise
stated or the context otherwise requires, the terms “Energous,” “we,” “us,” “our”
and the “Company” refer to Energous Corporation. References to our “common stock” refer to the common stock
of Energous Corporation.
All references in this prospectus supplement
to our financial statements include, unless the context indicates otherwise, the related notes.
Cautionary
Statement About Forward-Looking Information
This prospectus supplement, the accompanying
prospectus and the documents incorporated by reference herein or therein, contain forward-looking statements within the meaning
of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that
are intended to be covered by the “safe harbor” created by those sections. Forward-looking statements, which are based
on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking
terms such as “believe,” “expect,” “may,” “will,” “should,” “could,”
“seek,” “intend,” “plan,” “estimate,” “anticipate” or other comparable
terms. All statements other than statements of historical facts included in this prospectus supplement, the accompanying prospectus
and the documents incorporated by reference herein or therein regarding our strategies, prospects, financial condition, operations,
costs, plans and objectives are forward-looking statements. Examples of forward-looking statements include, among others, statements
we make regarding expectations for product shipments, revenues, liquidity and financial performance, the anticipated results of
our development efforts and the timing for receipt of required regulatory approvals and product launches. Forward-looking statements
are only on our current beliefs, expectations and assumptions regarding the future of our business, strategies, projections, anticipated
events and trends, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent
uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our
actual results and financial condition may differ materially from those indicated in our forward-looking statements. Therefore,
you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial
condition to differ materially from those indicated in the forward-looking statements include, among others: our ability to develop
commercially feasible technology; receipt of necessary regulatory approvals; our ability to find and maintain development partners;
market acceptance of our technology; the amount and nature of competition in our industry; our ability to protect our intellectual
property; other risks and uncertainties included in this prospectus supplement under the caption “Risk Factors;” and
risks and uncertainties described in documents incorporated by reference into this prospectus supplement and the accompanying prospectus.
We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments
or otherwise.
PROSPECTUS
SUPPLEMENT Summary
This summary highlights certain information
about us, this offering and selected information contained elsewhere in or incorporated by reference into this prospectus supplement
or the accompanying prospectus. This summary is not complete and does not contain all of the information that you should consider
before deciding whether to invest in our securities. For a more complete understanding of our company and this offering, we encourage
you to read and consider carefully the more detailed information in this prospectus supplement and the accompanying prospectus,
including the information under the heading “Risk Factors” in this prospectus supplement beginning on page S-6, in
the accompanying prospectus beginning on page 5, and in our most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q
and the information incorporated by reference in this prospectus supplement and the accompanying prospectus.
Company Overview
We have developed a technology called WattUp®
that consists of proprietary semiconductor chipsets, software, hardware designs and antennas that enables radio frequency (“RF”)
based charging for electronic devices, providing wire-free charging solutions for contact-based charging as well as at a distance
charging, ultimately enabling charging with mobility under full software control. We believe our proprietary technology can be
utilized in a variety of devices, including wearables, hearing aids, earbuds, Bluetooth headsets, Internet of Things (“IoT”)
devices, smartphones, tablets, e-book readers, keyboards, mice, remote controls, rechargeable lights, cylindrical batteries, medical
devices and any other device with similar charging requirements that would otherwise need a battery or a connection to a power
outlet.
We believe our technology is novel in its
approach, in that we are developing a solution that charges electronic devices by surrounding them with a focused, three-dimensional
RF energy pocket. We are engineering solutions that we expect to enable the wire-free transmission of energy for “near field”
contact-based applications as well as “far field” applications of up to 15 feet in radius or in a circular charging
envelope of up to 30 feet. We are also developing our far field transmitter technology to seamlessly mesh (much like a network
of WiFi routers) to form a wire-free charging network that will allow users to charge their devices as they walk from room-to-room
or throughout a large space. To date, we have developed multiple transmitter prototypes in various form factors and power capabilities.
In November 2016, we entered into a Strategic
Alliance Agreement with Dialog Semiconductor plc (“Dialog”), pursuant to which Dialog will manufacture and distribute
integrated circuit products incorporating our wire-free charging technology. Dialog will be our exclusive supplier of these products
for the general market. Our WattUp technology will use Dialog's SmartBond® Bluetooth low energy solution as the out-of-band
communications channel between the wireless transmitter and receiver. In most cases, Dialog's power management technology will
then be used to distribute power from the WattUp receiver integrated circuit to the rest of the device while Dialog's AC/DC Rapid
Charge™ power conversion technology delivers power to the wireless transmitter.
Recent Developments
FCC Certification for Power-at-a-Distance Wireless Charging
On December 26, 2017, we announced Federal
Communications Commission (FCC) certification of our first-generation WattUp Mid Field transmitter, which sends focused, RF-based
power to devices at a distance of up to three feet, while also charging multiple devices at once. Our WattUp Mid Field transmitter
underwent rigorous, multi-month testing to verify it met consumer safety and regulatory requirements. We believe this achievement
represents the first certification of a Part 18 FCC approved power-at-a-distance wireless charging transmitter, and also establishes
a precedent that will streamline both our future FCC and international regulatory approvals, as well as the regulatory approvals
of our customers for their respective end-products.
Preliminary Estimated Financial Information for the Fourth
Quarter of 2017
We have presented preliminary estimated
financial information below for our fourth quarter ended December 31, 2017 based on currently available information. We have not
finalized our financial results for the quarter and Marcum LLP, our independent registered public accounting firm, has not performed
any procedures with respect to the preliminary estimated financial information contained below, nor has Marcum expressed any opinion
or other assurance on such preliminary estimated financial information. These preliminary estimates should not be regarded as a
representation by us, our management or the sales agent as to our actual financial results for our fourth quarter. The preliminary
estimated financial information presented below is subject to change, and our actual financial results may differ from such preliminary
estimates and such differences could be material.
The following are preliminary estimates
for our fourth quarter ended December 31, 2017:
|
|
§
|
Revenue of $0.03 million;
|
|
|
§
|
GAAP operating expenses between $11.2 million and $11.5 million;
|
|
|
§
|
Depreciation and amortization expenses of approximately $0.3 million;
|
|
|
§
|
Stock-based compensation expense between $3.2 million and $3.45 million;
and
|
|
|
§
|
Cash and cash equivalents of approximately $12.8 million as of December
31, 2017.
|
Current Outlook
We are currently making the transition from
product development to commercial revenue generation from chip sales. During the fourth quarter of 2017, we began shipping chips
through Dialog to customers, but in limited quantities that were not recognized as revenue. We expect to recognize modest levels
of chip revenue in the first quarter of 2018. Growth in our chip revenue depends on a variety of factors, including our success
in securing design wins, and the success of our customers in commercializing their end-products and receiving regulatory approval
to sell their end-products to consumers. We expect end-products incorporating our Near Field transmitter technology to be available
to consumers in the first half of 2018, while end-products incorporating our Mid Field transmitter technology will be available
to consumers in the second half of 2018. We anticipate that shipments of our customers’ end-products will begin in modest
volumes and will grow over time based on consumer demand. Shipments of silicon chips for revenue will follow the same curve as
both the number of WattUp enabled products hit the market and consumer demand expands for the WattUp enable products in the market.
Given these factors, we expect that our chip revenue will remain at modest levels through the third quarter of 2018, with opportunities
for growth thereafter. We expect to continue generating engineering services revenue during 2018, although the timing and magnitude
of this revenue is difficult to predict.
Implications of Being an Emerging Growth Company
We are an “emerging growth company,”
as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, and, for as long as we continue to be an “emerging
growth company,” we may choose to take advantage of exemptions from various reporting requirements applicable to other public
companies but not to “emerging growth companies,” including, but not limited to, not being required to comply with
the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding
executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding
advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. We could
be an “emerging growth company” for up to five years, or until the earliest of (i) the last day of the first fiscal
year in which our annual gross revenues exceed $1.07 billion, (ii) the date that we become a “large accelerated filer”
as defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended, which would occur if the market value of our common
shares that is held by non-affiliates exceeds $700 million as of the last business day of our most recently completed second fiscal
quarter, or (iii) the date on which we have issued more than $1.07 billion in non-convertible debt during the preceding three-year
period. We are choosing to “opt out” of the extended transition periods available under the JOBS Act for complying
with new or revised accounting standards, and intend to take advantage of the other exemptions.
Corporate Information
We were incorporated in Delaware on October
30, 2012 under the name DvineWave, Inc. and changed our name to Energous Corporation in January 2014. The address of our corporate
headquarters is 3590 North First Street, Suite 210, San Jose, CA, 95134 and our telephone number is (408) 963-0200. Our website
can be accessed at
www.energous.com
. Our Internet website and the information contained therein or connected thereto are
not part of this prospectus supplement or the accompanying prospectus.
The Offering
|
Shares we are offering
|
|
Common stock, par value $0.00001 per share, having an aggregate offering price of up to $40,000,000.
|
|
|
|
|
|
Manner of offering
|
|
“At-the-market” offerings that may be made
from time to time through our sales agent, Raymond James & Associates, Inc., or Raymond James. See “Plan of Distribution.”
|
|
|
|
|
|
Use of proceeds
|
|
We intend to use the net proceeds from this offering, after deducting the sales agent’s commissions and our offering expenses, to fund our product development efforts, regulatory activities, business development and support functions, and for general and administrative expenses and other general corporate purposes. See “Use of Proceeds” for additional information.
|
|
|
|
|
|
Risk factors
|
|
Investing in our common stock involves a high degree of risk. You should carefully consider all the information included or incorporated by reference in this prospectus supplement prior to investing in our common stock. In particular, we urge you to carefully read the “Risk Factors” section of this prospectus supplement and in the documents incorporated by reference in this prospectus supplement and the accompanying prospectus.
|
|
|
|
|
|
Nasdaq Stock Market Symbol
|
|
“WATT”
|
Risk Factors
Before you make a decision to invest
in our securities, you should consider carefully the risks described below, together with other information in this prospectus
supplement, the accompanying prospectus and the information incorporated by reference herein and therein, including any risk factors
contained in our annual and other reports filed with the SEC. If any of the following events actually occur, our business, operating
results, prospects or financial condition could be materially and adversely affected. This could cause the trading price of our
common stock to decline and you may lose all or part of your investment. The risks described below are not the only ones that we
face. Additional risks not presently known to us or that we currently deem immaterial may also significantly impair our business
operations and could result in a complete loss of your investment.
Risks Related to Our Business
Other than engineering services revenues, we have no history
of generating meaningful product revenue, and we may never achieve or maintain profitability.
We have a limited operating history upon
which investors may rely in evaluating our business and its prospects. We have generated only very limited revenues to date and
we have a history of losses from operations. As of September 30, 2017 we had an accumulated deficit of approximately $163 million.
Our ability to generate revenues on a more reliable and larger scale, and to achieve profitability, will depend on our ability
to execute our business plan, complete the development of our technology, and incorporate it into products that customers wish
to buy, and to do so rapidly with appropriate financing if necessary. If we are unable to generate revenues of significant scale
to cover our costs of doing business, our losses will continue and we may not achieve profitability, which could negatively impact
the value of your investment in our securities.
Terms of our Development and License Agreement with a
tier-one consumer electronics company could inhibit potential licensees from working with us in specific markets.
We have entered into a Development and License
Agreement with a tier-one consumer electronics company to embed our WattUp wire-free charging receiver and transmitter technology
in various products, including mobile consumer electronics and related accessories. This agreement provides our strategic partner
a time-to-market advantage during the development and until one year after the first customer shipment for specified WattUp-enabled
consumer products. This may inhibit other potential licensees of our technology from engaging with us on competing consumer products,
and may cause them to seek solutions offered by other companies, which could have a negative impact on our revenue opportunities
and financial results.
We may be unable to demonstrate the feasibility of our
technology.
We have developed working prototypes of
products using our technology, but additional research and development is required to commercialize our technology for mid field
and far field applications so that it can be successfully integrated into commercial products. Our research and development efforts
remain subject to the risks associated with the development of new products that are based on emerging technologies, such as unanticipated
technical problems, the inability to identify products utilizing our technology that will be in demand with customers, getting
our technology designed in to those products, designing new products for manufacturability, and achieving acceptable price points
for final products. Our technology must also satisfy customer expectations and be suitable for them to use in consumer applications.
Any delays in developing our technology that arise from factors of this sort would aggravate our exposure to the risk of having
inadequate capital to fund the research and development needed to complete development of these products. Technical problems causing
delays would cause us to incur additional expenses that would increase our operating losses. If we experience significant delays
in developing our technology and products based on it for use in potential commercial applications, particularly after incurring
significant expenditures, our business may fail and you could lose the value of your investment in our company. To our knowledge,
the technological concepts we are applying have never previously been successfully applied. If we fail to develop practical and
economical commercial products based on our technology, our business may fail and you could lose the value of your investment in
our stock.
The FCC may deny approval for our technology, and future
legislative or regulatory changes may impair our business.
Our wire-free charging technology involves
transmission of power using radio frequency (RF) energy, which is subject to regulation by the Federal Communications Commission,
or FCC. It may also be subject to regulation by other federal, state and local agencies. We design our technology to operate in
a RF band that is also used for Wi-Fi routers and other wireless consumer electronics. Some customer applications may require us
to develop our technology to work at different frequencies. The FCC grants product approval if, among other things, the human exposure
to radio frequency emissions is below specified thresholds. For products that transmit more power, additional FCC approvals are
required. There can be no assurance that devices incorporating our technology will receive FCC approval or that other governmental
approvals will not be required. Our efforts to obtain FCC approval for devices using our technology is costly and time consuming.
If approvals are not obtained in a timely and cost-efficient manner, our business and operating results would be materially harmed.
In addition, new laws or regulations governing our technology could impose restrictions on us that could require us to redesign
our technology or future products, or that are difficult or impracticable to comply with, all of which would adversely affect our
revenues and financial results.
We are dependent upon our strategic relationship with
Dialog Semiconductor, a provider of electronics products, and there can be no assurance that we will achieve the expected benefits
of this relationship.
We have entered into a strategic cooperation
agreement with Dialog Semiconductor, a provider of electronics products, pursuant to which we licensed our WattUp technology to
Dialog and Dialog became the exclusive provider of our technology. We intend to leverage Dialog’s sales and distribution
channels and its operational capabilities to accelerate market adoption of our technology, while we focus our resources on research
and development of our technology. There can be no assurance that Dialog will promote our technology successfully, or that it will
be successful in producing and distributing related products to our customers’ specifications. Dialog may have other priorities
or may encounter difficulties in its own business that interfere with the success of our relationship. If this strategic relationship
does not work as we intend, then we may be required to seek an arrangement with another strategic partner, or to develop internal
capabilities, which will require a commitment of management time and our financial resources to identify a replacement strategic
partner, or to develop our own production and distribution capabilities. As a result, we may be unable without undue expense to
replace this agreement with one or more new strategic relationships to promote and provide our technology.
We may require additional financing in order to achieve
our business plans, and there is no guarantee that it will be available on acceptable terms, or at all.
We may not have sufficient funds to fully
implement our business plans. We expect that we will need to raise additional capital through new financings, even if we begin
to generate meaningful commercial revenue. Such financings could include equity financing, which may be dilutive to stockholders,
or debt financing, which could restrict our ability to borrow from other sources. In addition, such securities may contain rights,
preferences or privileges senior to those of current stockholders. As a result of economic conditions, general global economic
uncertainty, political change, and other factors, we do not know whether additional capital will be available when needed, or that,
if available, we will be able to obtain additional capital on reasonable terms. If we are unable to raise additional capital due
to the volatile global financial markets, general economic uncertainty or other factors, we may be required to curtail development
of our technology or reduce operations as a result, or to sell or dispose of assets. Any inability to raise adequate funds on commercially
reasonable terms could have a material adverse effect on our business, results of operations and financial condition, including
the possibility that a lack of funds could cause our business to fail and liquidate with little or no return to investors.
Expanding our business operations as we intend will impose
new demands on our financial, technical, operational and management resources.
To date we have operated primarily in the
research and development phase of our business. If we are successful, we will need to expand our business operations, which will
impose new demands on our financial, technical, operational and management resources. If we do not upgrade our technical, administrative,
operating and financial control systems, or the unexpected expansion difficulties arise, including issues relating to our research
and development activities and retention of experienced scientists, managers and engineers, could have a material adverse effect
on our business, our results of operations and financial condition, and our ability to timely execute our business plan. If we
are unable to implement these actions in a timely manner, our results may be adversely affected.
If products incorporating our technology are launched
commercially but do not achieve widespread market acceptance, we will not be able to generate the revenue necessary to support
our business.
Market acceptance of a wire-free charging
system as a preferred method to recharge low-power fixed and mobile electronic devices will be crucial to our continued success.
The following factors, among others, may affect the rate and level of market acceptance of products in our industry:
|
|
•
|
the price of products incorporating our technology relative to other products or competing technologies;
|
|
|
•
|
the effectiveness of sales and marketing efforts of our commercialization partners;
|
|
|
•
|
the support and rate of acceptance of our technology and solutions with our joint development partners;
|
|
|
•
|
perceptions, by individual and enterprise users, of our technology’s convenience, safety, efficiency and benefits compared to competing technologies;
|
|
|
•
|
press and blog coverage, social media coverage, and other publicity factors which are not within our control; and
|
|
|
•
|
regulatory developments.
|
If we are unable to achieve or maintain
market acceptance of our technology, and if related products do not win widespread market acceptance, our business will be significantly
harmed.
If products incorporating our technology are commercially
launched, we may experience seasonality or other unevenness in our financial results in consumer markets or a long and variable
sales cycle in enterprise markets.
Our strategy depends on the development
of successful commercial products and effectively licensing our technology into the consumer, enterprise and commercial markets.
We will need to understand procurement and buying cycles to be successful in licensing our technology. We anticipate it is possible
that demand for our technology could vary similarly with the market for products with which our technology may be used, for example,
the market for new purchases of laptops, tablet, mobile phones, gaming systems, toys, wearables and the like. Such consumer markets
are often seasonal, with peaks in and around the December holiday season and the August-September back-to-school season. Enterprises
and commercial markets may have annual or other budgeting and buying cycles that could affect us, and, particularly if we are designated
as a capital improvement project, we may have a long or unpredictable sales cycle.
We may not be able to achieve all the features we seek
to include in our technology.
We have developed working prototypes of
commercial products that utilize our technology. Additional features and performance specifications we seek to include in our technology
have not yet been developed. For example, some customer applications may require specific combinations of cost, footprint, efficiencies
and capabilities at various charging power levels and distances as part of an overall system. We believe our research and development
efforts will yield additional functionality and capabilities over time. However, there can be no assurance that we will be successful
in achieving all the features we are targeting and our inability to do so may limit the appeal of our technology to consumers.
Future products based on our technology may require the
user to purchase additional products to use with existing devices. To the extent these additional purchases are inconvenient, the
adoption of our technology under development or other future products could be slowed, which would harm our business.
For rechargeable devices that utilize our
receiver technology, the technology may be embedded in a sleeve, case or other enclosure. For example, products such as remote
controls or toys equipped with replaceable AA size or other batteries would need to be outfitted with enhanced batteries and other
hardware enabling the devices to be rechargeable by our system. In each case, an end user would be required to retrofit the device
with a receiver and may be required to upgrade the battery technology used with the device (unless, for example, compatible battery
technology and a receiver are built into the device). These additional steps and expenses may offset the convenience for some users
and discourage some users from purchasing our technology under development or other future products. Such factors may inhibit adoption
of our technology, which could harm our business. We have not developed an enhanced battery for use in devices with our technology,
and our ability to enable use of our technology with devices that require an enhanced battery will depend on our ability to develop
a commercial version of such a battery that could be manufactured at a reasonable cost. If we fail to develop or enable a commercially
practicable enhanced battery, our business could be harmed, and we may need to change our strategy and target markets.
Laboratory conditions differ from field conditions, which
could affect the effectiveness of our technology under development or other future products. Failures to move from laboratory to
the field effectively would harm our business.
When used in the field, our technology may
not perform as expected based on test results and performance of our technology under controlled laboratory circumstances. For
example, in the laboratory a configuration of obstructions of transmission will be arranged in some fashion, but in the field receivers
may be obstructed in many different and unpredictable ways over which we have no control. These conditions may significantly diminish
the power received at the receiver or the effective range of the transmitter, because the RF energy from the transmitter may be
absorbed by obscuring or blocking material or may need to be reflected off a surface to reach the receiver, making the transmission
distance longer than straight-line distances. The failure of products using our technology or other future products to be able
to meet the demands of users in the field could harm our business.
Safety concerns and legal action by private parties may
affect our business.
We believe that our technology is safe.
However, it is possible that we could discover safety issues with our technology or that some people may be concerned with wire-free
transmission of power in a manner that has occurred with some other wireless technologies as they were put into residential and
commercial use, such as the safety concerns that were raised by some regarding the use of cellular telephones and other devices
to transmit data wirelessly in close proximity to the human body. In addition, while we believe our technology is safe, users of
our technology under development or other future products who suffer medical ailments may blame the use of products incorporating
our technology, as occurred with a small number of users of cellular telephones. A discovery of safety issues relating to our technology
could have a material adverse effect on our business and any legal action against us claiming our technology caused harm could
be expensive, divert management and adversely affect us or cause our business to fail, whether or not such legal actions were ultimately
successful.
Our industry is subject to intense competition and rapid
technological change, which may result in technology that is superior to ours. If we are unable to keep pace with changes in the
marketplace and the direction of technological innovation and customer demands, our technology and products may become less useful
or obsolete and our operating results will suffer.
The consumer electronics industry in general,
and the power, recharging and alternative recharging segments in particular, are subject to intense and increasing competition
and rapidly evolving technologies. Because products incorporating our technology are expected to have long development cycles,
we must anticipate changes in the marketplace and the direction of technological innovation and customer demands. To compete successfully,
we will need to demonstrate the advantages of our products and technologies over established alternatives, and over newer methods
of power delivery. Traditional wall plug-in recharging remains an inexpensive alternative to our technology. Directly competing
technologies such as inductive charging, magnetic resonance charging, conductive charging, ultrasound and other yet unidentified
solutions may have greater consumer acceptance than the technologies we have developed. Furthermore, certain competitors may have
greater resources than we have and may be better established in the market than we are. We cannot be certain which other companies
may have already decided to or may in the future choose to enter our markets. For example, consumer electronics products companies
may invest substantial resources in wireless power or other recharging technologies and may decide to enter our target markets.
Successful developments of competitors that result in new approaches for recharging could reduce the attractiveness of our products
and technologies or render them obsolete.
Our future success will depend in large
part on our ability to establish and maintain a competitive position in current and future technologies. Rapid technological development
may render our technology or future products based on our technology obsolete. Many of our competitors have greater corporate,
financial, operational, sales and marketing resources than we have, as well as more experience in research and development. We
cannot assure you that our competitors will not develop or market technologies that are more effective or commercially attractive
than our products or that would render our technologies and products obsolete. We may not have or the financial resources, technical
expertise, marketing, distribution or support capabilities to compete successfully in the future. Our success will depend in large
part on our ability to maintain a competitive position with our technologies.
Our competitive position also depends on
our ability to:
|
|
•
|
generate widespread awareness, acceptance and adoption by the consumer and enterprise markets of our technology under development and future products;
|
|
|
•
|
design a product that may be sold at an acceptable price point;
|
|
|
•
|
develop new or enhanced technologies or features that improve the convenience, efficiency, safety or perceived safety, and productivity of our technology under development and future products;
|
|
|
•
|
properly identify customer needs and deliver new products or product enhancements to address those needs;
|
|
|
•
|
limit the time required from proof of feasibility to routine production;
|
|
|
•
|
limit the timing and cost of regulatory approvals;
|
|
|
•
|
attract and retain qualified personnel;
|
|
|
•
|
protect our inventions with patents or otherwise develop proprietary products and processes; and
|
|
|
•
|
secure sufficient capital resources to expand both our continued research and development, and sales and marketing efforts.
|
If our technology does not compete well based on these or other
factors, our business could be harmed.
It is difficult and costly to protect our intellectual
property and our proprietary technologies, and we may not be able to ensure their protection.
Our success depends significantly on our
ability to obtain, maintain and protect our proprietary rights to the technologies used in products incorporating our technologies.
Patents and other proprietary rights provide uncertain protections, and we may be unable to protect our intellectual property.
For example, we may be unsuccessful in defending our patents and other proprietary rights against third party challenges. If we
do not have the resources to defend our intellectual property, the value of our intellectual property and our licensed technology
will decline, threatening our potential revenue and results of operations.
We depend upon a combination of patent, trade secrets,
copyright and trademark laws to protect our intellectual property and technology.
We rely on a combination of patents, trade
secrets, copyright and trademark laws, nondisclosure agreements and other contractual provisions and technical security measures
to protect our intellectual property rights. These measures may not be adequate to safeguard our technology. If they do not protect
our rights adequately, third parties could use our technology, and our ability to compete in the market would be reduced. Although
we are attempting to obtain patent coverage for our technology where available and where we believe appropriate, there are aspects
of the technology for which patent coverage may never be sought or received. We may not possess the resources to or may not choose
to pursue patent protection outside the United States or any or every country other than the United States where we may eventually
decide to sell our future products. Our ability to prevent others from making or selling duplicate or similar technologies will
be impaired in those countries in which we have no patent protection. Although we have a number of patent applications on file
in the United States, the patents may not issue, may issue only with limited coverage or may issue and be subsequently successfully
challenged by others and held invalid or unenforceable.
Similarly, even if patents do issue based
on our applications or future applications, any issued patents may not provide us with any competitive advantages. Competitors
may be able to design around our patents or develop products that provide outcomes comparable or superior to ours. Our patents
may be held invalid or unenforceable as a result of legal challenges by third parties, and others may challenge the inventorship
or ownership of our patents and pending patent applications. In addition, if we secure protection in countries outside the United
States, the laws of some foreign countries may not protect our intellectual property rights to the same extent as do the laws of
the United States. In the event a competitor infringes upon our patent or other intellectual property rights, enforcing those rights
may be difficult and time consuming. Even if successful, litigation to enforce our intellectual property rights or to defend our
patents against challenge could be expensive and time consuming and could divert our management’s attention. We may not have
sufficient resources to enforce our intellectual property rights or to defend our patents against a challenge.
Our strategy is to deploy our technology
into the market by licensing patent and other proprietary rights to third parties and customers. Disputes with our licensors may
arise regarding the scope and content of these licenses. Further, our ability to expand into additional fields with our technologies
may be restricted by existing licenses or licenses we may grant to third parties in the future.
The policies we use to protect our trade
secrets may not be effective in preventing misappropriation of our trade secrets by others. In addition, confidentiality agreements
executed by our employees, consultants and advisors may not be enforceable or may not provide meaningful protection for our trade
secrets or other proprietary information in the event of unauthorized use or disclosure. Litigating a trade secret claim is expensive
and time consuming, and the outcome is unpredictable. Moreover, our competitors may independently develop equivalent knowledge
methods and know-how. If we are unable to protect our intellectual property rights, we may be unable to prevent competitors from
using our own inventions and intellectual property to compete against us, and our business may be harmed.
We may be subject to patent infringement or other intellectual
property lawsuits that could be costly to defend.
Because our industry is characterized by
competing intellectual property, we may become involved in litigation based on claims that we have violated the intellectual property
rights of others. Determining whether a product infringes a patent involves complex legal and factual issues, and the outcome of
patent litigation actions is often uncertain. No assurance can be given that third party patents containing claims covering our
products, parts of our products, technology or methods do not exist, have not been filed, or could not be filed or issued. Because
of the number of patents issued and patent applications filed in our technical areas or fields (including some pertaining specifically
to wireless charging technologies), our competitors or other third parties may assert that our products and technology and the
methods we employ in the use of our products and technology are covered by United States or foreign patents held by them. In addition,
because patent applications can take many years to issue and because publication schedules for pending applications vary by jurisdiction,
there may be applications now pending which may result in issued patents that our technology under development or other future
products would infringe. Also, because the claims of published patent applications can change between publication and patent grant,
there may be published patent applications that may ultimately issue with claims that we infringe. There could also be existing
patents that one or more of our technologies, products or parts may infringe and of which we are unaware. As the number of competitors
in the market for wire-free power and alternative recharging solutions increases, and as the number of patents issued in this area
grows, the possibility of patent infringement claims against us increases. Some of our competitors may be able to sustain the costs
of complex patent litigation more effectively than we can because they have substantially greater resources. In addition, any uncertainties
resulting from the initiation and continuation of any litigation could have a material adverse effect on our ability to raise the
funds necessary to continue our operations.
In the event that we become subject to a
patent infringement or other intellectual property lawsuit and if the relevant patents or other intellectual property were upheld
as valid and enforceable and we were found to infringe or violate the terms of a license to which we are a party, we could be prevented
from selling any infringing products of ours unless we could obtain a license or were able to redesign the product to avoid infringement.
If we were unable to obtain a license or successfully redesign, we might be prevented from selling our technology under development
or other future products. If there is a determination that we have infringed the intellectual property rights of a competitor or
other person, we may be required to pay damages, pay a settlement, or pay ongoing royalties, or be enjoined. In these circumstances,
we may be unable to sell our products or license our technology at competitive prices or at all, and our business and operating
results could be harmed.
We could become subject to product liability claims,
product recalls, and warranty claims that could be expensive, divert management’s attention and harm our business.
Our business exposes us to potential liability
risks that are inherent in the marketing and sale of products used by consumers. We may be held liable if our technology under
development now or in the future causes injury or death or are found otherwise unsuitable during usage. Our technology under development
incorporates sophisticated components and computer software. Complex software can contain errors, particularly when first introduced.
In addition, new products or enhancements may contain undetected errors or performance problems that, despite testing, are discovered
only after installation. While we believe our technology is safe, users could allege or possibly prove defects (some of which could
be alleged or proved to cause harm to users or others) because we design our technology to perform complex functions involving
RF energy, possibly in close proximity to users. A product liability claim, regardless of its merit or eventual outcome, could
result in significant legal defense costs. The coverage limits of our insurance policies we may choose to purchase to cover related
risks may not be adequate to cover future claims. If sales of products incorporating our technology increase or we suffer future
product liability claims, we may be unable to maintain product liability insurance in the future at satisfactory rates or with
adequate amounts. A product liability claim, any product recalls or excessive warranty claims, whether arising from defects in
design or manufacture or otherwise, could negatively affect our sales or require a change in the design or manufacturing process,
any of which could harm our reputation and business, harm our relationship with licensors of our products, result in a decline
in revenue and harm our business.
In addition, if a product that we or a strategic
partner design is defective, whether due to design or manufacturing defects, improper use of the product or other reasons, we or
our strategic partners may be required to notify regulatory authorities and/or to recall the product. A required notification to
a regulatory authority or recall could result in an investigation by regulatory authorities of products incorporating our technology,
which could in turn result in required recalls, restrictions on the sale of such products or other penalties. The adverse publicity
resulting from any of these actions could adversely affect the perception of our customers and potential customers. These investigations
or recalls, especially if accompanied by unfavorable publicity, could result in our incurring substantial costs, losing revenues
and damaging our reputation, each of which would harm our business.
We are subject to risks associated with our utilization
of consultants.
To improve productivity and accelerate our
development efforts while we build out our own engineering team, we may use experienced consultants to assist in selected development
projects. We take steps to monitor and regulate the performance of these independent third parties. However, arrangements with
third party service providers may make our operations vulnerable if these consultants fail to satisfy their obligations to us as
a result of their performance, changes in their own operations, financial condition, or other matters outside of our control. Effective
management of our consultants is important to our business and strategy. The failure of our consultants to perform as anticipated
could result in substantial costs, divert management’s attention from other strategic activities, or create other operational
or financial problems for us. Terminating or transitioning arrangements with key consultants could result in additional costs and
a risk of operational delays, potential errors and possible control issues as a result of the termination or during the transition.
If we are not able to secure advantageous license agreements
for our technology, our business and results of operations will be adversely affected.
We pursue the licensing of our technology
as a primary means of revenue generation. We believe there are many companies that would be interested in implementing our technology
into their devices. We have entered into one product development and license agreement with a tier-one consumer electronics company
that has the potential to yield license revenue. We have also entered into a number of evaluation and joint development agreements
with potential strategic partners. However, these agreements do not commit either party to a long-term relationship and any of
these parties may disengage with us at any time. Creating a licensing business relationship often takes a substantial effort, as
we expect to have to convince the counterparty of the efficacy of our technology, meet design and manufacturing requirements, satisfy
marketing and product needs, and comply with selection, review and contracting requirements. There can be no assurance that we
will be able to gain access to potential licensing partners, or that they will ultimately decide to integrate our technology with
their products. We may not be able to secure license agreements with customers on advantageous terms, and the timing and volume
of revenue earned from license agreements will be outside of our control. If the license agreements we enter into do not prove
to be advantageous to us, our business and results of operations will be adversely affected.
We are highly dependent on key members of our executive
management team. Our inability to retain these individuals could impede our business plan and growth strategies, which could have
a negative impact on our business and the value of your investment.
Our ability to implement our business plan
depends, to a critical extent, on the continued efforts and services of a very small number of key executives. If we lose the services
of any of these persons, we could be required to expend significant time and money in the pursuit of replacements, which may result
in a delay in the implementation of our business plan and plan of operations. If necessary, we can give no assurance that we could
find satisfactory replacements for these individuals on terms that would not be unduly expensive or burdensome to us. We do not
currently carry a key-man life insurance policy that would assist us in recouping our costs in the event of the death or disability
of any of these executives.
Our success and growth depend on our ability to attract,
integrate and retain high-level engineering talent.
Because of the highly specialized and complex
nature of our business, our success depends on our ability to attract, hire, train, integrate and retain high-level engineering
talent. Competition for such personnel is intense because we compete for talent against many large profitable companies and our
inability to adequately staff our operations with highly qualified and well-trained engineers could render us less efficient and
impede our ability to develop and deliver a commercial product. Such a competitive market could put upward pressure on labor costs
for engineering talent. We may incur significant costs to attract and retain highly qualified talent, and we may lose new employees
to our competitors or other technology companies before we realize the benefit of our investment in recruiting and training them.
Volatility or lack of performance in our stock price may also affect our ability to attract and retain qualified personnel.
Risks Related to Ownership of Our Common Stock
You may lose all of your investment.
Investing in our common stock involves a
high degree of risk. As an investor, you may never recoup all, or even part of, your investment and you may never realize any return
on your investment. You must be prepared to lose all of your investment.
Our stock price is likely to continue to be volatile.
The market price of the common stock has
fluctuated significantly since it was first listed on The Nasdaq Stock Market on March 28, 2014. Our common stock has experienced
an intra-day trading high of $33.50 per share and a low of $6.91 per share over the last 52 weeks. The price of our common stock
may continue to fluctuate significantly in response to factors, many of which are beyond our control, including the following:
|
|
•
|
Regulatory announcements, such as the recent FCC approval of our mid-range transmitter and receiver technology;
|
|
|
•
|
actual or anticipated variations in operating results;
|
|
|
•
|
the limited number of holders of the common stock;
|
|
|
•
|
changes in the economic performance and/or market valuations of other technology companies;
|
|
|
•
|
our announcements of significant strategic partnerships, regulatory developments and other events;
|
|
|
•
|
announcements by other companies in the wire-free charging space;
|
|
|
•
|
articles published or rumors circulated by third parties regarding our business, technology or development partners;
|
|
|
•
|
additions or departures of key personnel; and
|
|
|
•
|
sales or other transactions involving our capital stock.
|
We are an “emerging growth company,” and are
able to take advantage of reduced disclosure requirements applicable to “emerging growth companies,” which could make
our common stock less attractive to investors.
We are an “emerging growth company,”
as defined in the Jumpstart Our Business Startups Act of 2012, or JOBS Act, and, for as long as we continue to be an “emerging
growth company,” we intend to take advantage of certain exemptions from various reporting requirements applicable to other
public companies but not to “emerging growth companies,” including, but not limited to, not being required to comply
with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive
compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory
vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. We could be an
“emerging growth company” for up to five years, or until the earliest of (i) the last day of the first fiscal year
in which our annual gross revenues exceed $1.07 billion, (ii) the date that we become a “large accelerated filer” as
defined in Rule 12b-2 under the Exchange Act, which would occur if the market value of our common stock that is held by non-affiliates
exceeds $700.0 million as of the last business day of our most recently completed second fiscal quarter, or (iii) the date on which
we have issued more than $1.07 billion in non-convertible debt during the preceding three year period. We cannot predict if investors
will find our common stock less attractive if we choose to rely on these exemptions. If some investors find our common stock less
attractive as a result of any choices to reduce future disclosure, there may be a less active trading market for our common stock
and our stock price may be more volatile.
We have not paid dividends in the past and have no immediate
plans to pay dividends.
We plan to reinvest all of our earnings,
to the extent we have earnings, in order to market our products and technology and to cover operating costs and to otherwise become
and remain competitive. We do not plan to pay any cash dividends with respect to our securities in the foreseeable future. We cannot
assure you that we would, at any time, generate sufficient surplus cash that would be available for distribution to the holders
of our common stock as a dividend.
Concentration of ownership among our existing executive
officers, directors and significant stockholders may prevent new investors from influencing significant corporate decisions.
All decisions with respect to the management
of our company are made by our board of directors and our officers, who beneficially own approximately 9% of our common stock collectively.
In addition, our greater than 5% stockholders such as Dialog Semiconductor plc, Emily and Malcolm Fairbairn, Hood River Capital
Management, and DvineWave beneficially owned approximately 13.3%, 7.7%, 7.4% and 7.4%, respectively, of our common stock as of
December 31, 2017. As a result, these stockholders will be able to exercise a significant level of control over all matters requiring
stockholder approval, including the election of directors, amendment of our certificate of incorporation and approval of significant
corporate transactions. This control could have the effect of delaying or preventing a change of control of our company or changes
in management and will make the approval of certain transactions difficult or impossible without the support of these stockholders.
We expect to continue to incur significant costs as a
result of being a public reporting company and our management will be required to devote substantial time to meet our compliance
obligations.
As a public reporting company, we incur
significant legal, accounting and other expenses. We are subject to reporting requirements of the Securities Exchange Act of 1934
and rules subsequently implemented by the Securities and Exchange Commission (“SEC”) that require us to establish and
maintain effective disclosure controls and financial controls, as well as some specific corporate governance practices. Our management
and other personnel are expected to devote a substantial amount of time to compliance initiatives associated with our public reporting
company status.
We may be subject to securities litigation, which is expensive
and could divert management attention.
Our stock price has fluctuated in the past,
most recently following our announcement of FCC approval of our mid-field transmitter technology, and it may be volatile in the
future. In the past, companies that have experienced volatility in the market price of their securities have been subject to securities
class action litigation, and we may be the target of litigation of this sort in the future. Securities litigation is costly and
can divert management attention from other business concerns, which could seriously harm our business and the value of your investment
in our company.
An active trading market for our common stock may not
be maintained.
Our stock is currently traded on The Nasdaq
Stock Market, but we can provide no assurance that we will be able to maintain an active trading market on The Nasdaq Stock Market
or any other exchange in the future. If an active market for our common stock is not maintained, it may be difficult for our stockholders
to sell shares without depressing the market price for the shares or at all. An inactive market may also impair our ability to
raise capital to continue to fund operations by selling shares and may impair our ability to acquire other companies or technologies
by using our shares as consideration.
If securities or industry analysts do not publish research
or reports about our business, or publish negative reports about our business, our stock price and trading volume could decline.
The trading market for our common stock
will depend in part on the research and reports that securities or industry analysts publish about us or our business. We do not
have any control over these analysts. There can be no assurance that analysts will continue to cover us or provide favorable coverage.
If one or more of the analysts who cover us downgrade our stock or change their opinion of our stock, our stock price would likely
decline. If one or more of these analysts cease coverage of our company or fail to regularly publish reports on us, we could lose
visibility in the financial markets, which could cause our stock price or trading volume to decline.
Our charter documents and Delaware law may inhibit a takeover
that stockholders consider favorable.
Provisions of our certificate of incorporation
and bylaws, and applicable Delaware law, may delay or discourage transactions involving an actual or potential change in control
or change in our management, including transactions in which stockholders might otherwise receive a premium for their shares, or
transactions that our stockholders might otherwise deem to be in their best interests. The provisions in our certificate of incorporation
and bylaws:
|
|
•
|
authorize our board of directors to issue preferred stock without stockholder approval and to designate the rights, preferences and privileges of each class; if issued, such preferred stock would increase the number of outstanding shares of our capital stock and could include terms that may deter an acquisition of us;
|
|
|
•
|
limit who may call stockholder meetings;
|
|
|
•
|
do not permit stockholders to act by written consent;
|
|
|
•
|
do not provide for cumulative voting rights; and
|
|
|
•
|
provide that all vacancies may be filled by the affirmative vote of a majority of directors then in office, even if less than a quorum.
|
In addition, Section 203 of the Delaware
General Corporation Law may limit our ability to engage in any business combination with a person who beneficially owns 15% or
more of our outstanding voting stock unless certain conditions are satisfied. This restriction lasts for a period of three years
following the share acquisition. These provisions may have the effect of entrenching our management team and may deprive you of
the opportunity to sell your shares to potential acquirers at a premium over prevailing prices. This potential inability to obtain
a control premium could reduce the price of our common stock.
Risks Related to this Offering
Our management will have broad discretion
as to the use of proceeds from this offering and we may not use the proceeds effectively.
Our management will have broad discretion
in the application of the net proceeds from this offering, if any, and could spend the proceeds in ways that do not improve our
results of operations or enhance the value of our common stock. You will be relying on the judgment of our management concerning
these uses and you will not have the opportunity, as part of your investment decision, to assess whether the proceeds are being
used appropriately. The failure of our management to apply these funds effectively could result in unfavorable returns and uncertainty
about our prospects, each of which could cause the price of our common stock to decline.
The exercise of our outstanding options
and warrants and the vesting of our outstanding restricted stock units will dilute stockholders and could decrease our stock price.
The exercise of our outstanding options
and warrants and the vesting of our outstanding restricted stock units may adversely affect our stock price due to sales of a large
number of shares or the perception that such sales could occur. These factors also could make it more difficult to raise funds
through future offerings of our securities, and could adversely impact the terms under which we could obtain additional equity
capital. Exercise of outstanding options and warrants, vesting of outstanding restricted stock units or any future issuance of
additional shares of common stock or other equity securities, including but not limited to options, warrants, restricted stock
units or other derivative securities convertible into our common stock, may result in significant dilution to our stockholders
and may decrease our stock price.
The shares of our common stock offered
under this prospectus supplement and the accompanying base prospectus may be sold in “at-the-market” offerings, and
investors who buy shares at different times will likely pay different prices.
Investors who purchase shares under this
prospectus supplement and the accompanying base prospectus at different times will likely pay different prices, and so may experience
different outcomes in their investment results. We will have discretion, subject to market demand, to vary the timing, prices,
and numbers of shares sold, and to determine the minimum sales price for shares sold. Investors may experience declines in the
value of their shares as a result of share sales made in connection with “at-the-market” offerings at prices lower
than the prices they paid.
The actual number of shares we will issue under the distribution
agreement, at any one time or in total, is uncertain.
Subject to certain limitations in the distribution
agreement and compliance with applicable law, we and our sales agent may mutually agree to sell shares of our common stock under
a transaction acceptance at any time throughout the term of the distribution agreement. The number of shares that are sold by Raymond
James after agreement on the terms of the transaction acceptance will fluctuate based on the market price of the shares of our
common stock during the sales period and limits we set with our sales agent. Because the price per share of each share sold will
fluctuate based on the market price of our shares of common stock during the sales period, it is not possible to predict the number
of shares that will ultimately be issued.
Use of Proceeds
We may issue and sell shares of our common
stock having aggregate sale proceeds of up to $40,000,000 from time to time. There can be no assurance that we will be able to
sell any shares under or fully utilize the sales agreement with Raymond James as a source of financing. Because there is no minimum
offering amount required as a condition to close this offering, the actual total public offering amount, commissions and proceeds
to us, if any, are not determinable at this time. We currently intend to use the net proceeds from this offering to fund our product
development efforts, regulatory activities, business development and support functions, and for general and administrative expenses
and other general corporate purposes. The amounts and timing of our use of proceeds will vary depending on many factors, including
regulatory developments, the amount of cash generated or used by our operations, and the rate of growth, if any, of our business.
As a result, we will retain broad discretion in the allocation of the net proceeds, if any, we receive in connection with securities
offered pursuant to this prospectus supplement and investors will be relying on the judgment of our management regarding the application
of the proceeds.
Until we use the net proceeds of this offering,
we intend to invest the funds in short-term, investment-grade, interest-bearing securities.
MATERIAL
UNITED STATES FEDERAL INCOME TAX CONSEQUENCES
FOR NON-U.S. HOLDERS OF OUR COMMON STOCK
The following summary describes the material
U.S. federal income tax consequences of the acquisition, ownership and disposition of our common stock acquired in this offering
by Non-U.S. Holders (as defined below). This discussion does not address all aspects of U.S. federal income taxes, does not discuss
the potential application of the alternative minimum tax or Medicare Contribution tax and does not deal with state or local taxes,
U.S. federal gift and estate tax laws, except to the limited extent provided below, or any non-U.S. tax consequences that may be
relevant to Non-U.S. Holders in light of their particular circumstances.
Special rules different from those described
below may apply to certain Non-U.S. Holders that are subject to special treatment under the Internal Revenue Code of 1986, as amended,
or Code, such as:
|
|
·
|
insurance companies, banks and other financial institutions;
|
|
|
·
|
tax-exempt organizations (including private foundations) and tax-qualified
retirement plans;
|
|
|
·
|
foreign governments and international organizations;
|
|
|
·
|
broker-dealers and traders in securities;
|
|
|
·
|
U.S. expatriates and certain former citizens or long-term residents
of the United States;
|
|
|
·
|
persons that own, or are deemed to own, more than 5% of our capital
stock;
|
|
|
·
|
"controlled foreign corporations," "passive foreign
investment companies" and corporations that accumulate earnings to avoid U.S. federal income tax;
|
|
|
·
|
persons that hold our common stock as part of a "straddle,"
"hedge," "conversion transaction," "synthetic security" or integrated investment or other risk reduction
strategy;
|
|
|
·
|
persons who do not hold our common stock as a capital asset within
the meaning of Section 1221 of the Code (generally, for investment purposes); and
|
|
|
·
|
partnerships and other pass-through entities, and investors in such
pass-through entities (regardless of their places of organization or formation).
|
Such Non-U.S. Holders are urged to consult
their own tax advisors to determine the U.S. federal, state, local and other tax consequences that may be relevant to them.
Furthermore, the discussion below is based
upon the provisions of the Code, and Treasury regulations, rulings and judicial decisions thereunder as of the date hereof, and
such authorities may be repealed, revoked or modified, possibly retroactively, and are subject to differing interpretations which
could result in U.S. federal income tax consequences different from those discussed below. We have not requested a ruling from
the Internal Revenue Service, or IRS, with respect to the statements made and the conclusions reached in the following summary,
and there can be no assurance that the IRS will agree with such statements and conclusions or will not take a contrary position
regarding the tax consequences described herein, or that any such contrary position would not be sustained by a court.
PERSONS CONSIDERING THE PURCHASE OF OUR COMMON
STOCK PURSUANT TO THIS OFFERING SHOULD CONSULT THEIR OWN TAX ADVISORS CONCERNING THE U.S. FEDERAL INCOME TAX CONSEQUENCES OF ACQUIRING,
OWNING AND DISPOSING OF OUR COMMON STOCK IN LIGHT OF THEIR PARTICULAR SITUATIONS AS WELL AS ANY CONSEQUENCES ARISING UNDER THE
LAWS OF ANY OTHER TAXING JURISDICTION, INCLUDING ANY STATE, LOCAL OR NON-U.S. TAX CONSEQUENCES OR ANY U.S. FEDERAL NON-INCOME TAX
CONSEQUENCES, AND THE POSSIBLE APPLICATION OF TAX TREATIES.
For the purposes of this discussion, a "Non-U.S.
Holder" is, for U.S. federal income tax purposes, a beneficial owner of common stock that is not a U.S. Holder or a partnership
for U.S. federal income tax purposes. A "U.S. Holder" means a beneficial owner of our common stock that is for U.S. federal
income tax purposes (a) an individual citizen or resident of the United States, (b) a corporation (or other entity taxable as a
corporation for U.S. federal income tax purposes), created or organized in or under the laws of the United States, any state thereof
or the District of Columbia, (c) an estate the income of which is subject to U.S. federal income taxation regardless of its source,
or (d) a trust if it (1) is subject to the primary supervision of a court within the United States and one or more U.S. persons
(within the meaning of Section 7701(a)(30) of the Code) have the authority to control all substantial decisions of the trust or
(2) has a valid election in effect under applicable U.S. Treasury regulations to be treated as a U.S. person.
If you are an individual non-U.S. citizen,
you may, in some cases, be deemed to be a resident alien (as opposed to a nonresident alien) by virtue of being present in the
United States for at least 31 days in the calendar year and for an aggregate of at least 183 days during a three-year period ending
in the current calendar year. Generally, for this purpose, all the days present in the current year, one-third of the days present
in the immediately preceding year, and one-sixth of the days present in the second preceding year, are counted.
Resident aliens are generally subject to
U.S. federal income tax as if they were U.S. citizens. Individuals who are uncertain of their status as resident or nonresident
aliens for U.S. federal income tax purposes are urged to consult their own tax advisors regarding the U.S. federal income tax consequences
of the ownership or disposition of our common stock.
Distributions
We do not expect to make any distributions
on our common stock in the foreseeable future. If we do make distributions on our common stock, however, such distributions made
to a Non-U.S. Holder of our common stock will constitute dividends for U.S. tax purposes to the extent paid out of our current
or accumulated earnings and profits (as determined under U.S. federal income tax principles). Distributions in excess of our current
and accumulated earnings and profits will constitute a return of capital that is applied against and reduces, but not below zero,
a Non-U.S. Holder's adjusted tax basis in our common stock. Any remaining excess will be treated as gain realized on the sale or
exchange of our common stock as described below under the section titled "—Gain on Disposition of Our Common Stock."
Any distribution on our common stock that
is treated as a dividend paid to a Non-U.S. Holder that is not effectively connected with the holder's conduct of a trade or business
in the United States will generally be subject to withholding tax at a 30% rate or such lower rate as may be specified by an applicable
income tax treaty between the United States and the Non-U.S. Holder's country of residence. To obtain a reduced rate of withholding
under a treaty, a Non-U.S. Holder generally will be required to provide the applicable withholding agent with a properly executed
IRS Form W-8BEN, IRS Form W-8BEN-E or other appropriate form, certifying the Non-U.S. Holder's entitlement to benefits under that
treaty. Such form must be provided prior to the payment of dividends and must be updated periodically. If a Non-U.S. Holder holds
stock through a financial institution or other agent acting on the holder's behalf, the holder will be required to provide appropriate
documentation to such agent. The holder's agent may then be required to provide certification to the applicable withholding agent,
either directly or through other intermediaries. If you are eligible for a reduced rate of U.S. withholding tax under an income
tax treaty, you should consult with your own tax advisor to determine if you are able to obtain a refund or credit of any excess
amounts withheld by timely filing an appropriate claim for a refund with the IRS.
We generally are not required to withhold
tax on dividends paid to a Non-U.S. Holder that are effectively connected with the holder's conduct of a trade or business within
the United States (and, if required by an applicable income tax treaty, are attributable to a permanent establishment that the
holder maintains in the United States) if a properly executed IRS Form W-8ECI, stating that the dividends are so connected, is
furnished to us (or, if stock is held through a financial institution or other agent, to the applicable withholding agent). In
general, such effectively connected dividends will be subject to U.S. federal income tax on a net income basis at the regular graduated
rates applicable to U.S. persons, unless a specific treaty exemption applies. A corporate Non-U.S. Holder receiving effectively
connected dividends may also be subject to an additional "branch profits tax," which is imposed, under certain circumstances,
at a rate of 30% (or such lower rate as may be specified by an applicable treaty) on the corporate Non-U.S. Holder's effectively
connected earnings and profits, subject to certain adjustments.
See also the section below titled "—Foreign Accounts"
for additional withholding rules that may apply to dividends paid to certain foreign financial institutions or non-financial foreign
entities.
Gain on Disposition of Our Common
Stock
Subject to the discussions below under the
sections titled "—Backup Withholding and Information Reporting" and "—Foreign Accounts," a Non-U.S.
Holder generally will not be subject to U.S. federal income or withholding tax with respect to gain realized on a sale or other
disposition of our common stock unless (a) the gain is effectively connected with a trade or business of the holder in the United
States (and, if required by an applicable income tax treaty, is attributable to a permanent establishment that the holder maintains
in the United States), (b) the Non-U.S. Holder is a nonresident alien individual and is present in the United States for 183 or
more days in the taxable year of the disposition and certain other conditions are met, or (c) we are or have been a "United
States real property holding corporation" within the meaning of Code Section 897(c)(2) at any time within the shorter of the
five-year period preceding such disposition or the holder's holding period in the common stock.
If you are a Non-U.S. Holder described in
(a) above, you will be required to pay tax on the net gain derived from the sale at the regular graduated U.S. federal income tax
rates applicable to U.S. persons, unless a specific treaty exemption applies. Corporate Non-U.S. Holders described in (a) above
may also be subject to the additional branch profits tax at a 30% rate or such lower rate as may be specified by an applicable
income tax treaty. If you are an individual Non-U.S. Holder described in (b) above, you will be required to pay a flat 30% tax
on the gain derived from the sale, which gain may be offset by U.S. source capital losses (even though you are not considered a
resident of the United States), provided you have timely filed U.S. federal income tax returns with respect to such losses. With
respect to (c) above, in general, we would be a U.S. real property holding corporation if interests in U.S. real estate comprised
(by fair market value) at least half of our assets. We believe that we are not, and do not anticipate becoming, a U.S. real property
holding corporation. However, there can be no assurance that we will not become a U.S. real property holding corporation in the
future. Even if we are treated as a U.S. real property holding corporation, gain realized by a Non-U.S. Holder on a disposition
of our common stock will not be subject to U.S. federal income tax so long as (1) the Non-U.S. Holder owned, directly, indirectly
or constructively, no more than five percent of our common stock at all times within the shorter of (i) the five-year period preceding
the disposition or (ii) the holder's holding period and (2) our common stock is regularly traded on an established securities market.
There can be no assurance that our common stock will continue to qualify as regularly traded on an established securities market.
See the section titled "—Foreign
Accounts" for additional information regarding withholding rules that may apply to proceeds of a disposition of our common
stock paid to foreign financial institutions or non-financial foreign entities.
U.S. Federal Estate Tax
The estates of nonresident alien individuals
generally are subject to U.S. federal estate tax on property with a U.S. situs. Because we are a U.S. corporation, our common stock
will be U.S. situs property and, therefore, will be included in the taxable estate of a nonresident alien decedent, unless an applicable
estate tax treaty between the United States and the decedent's country of residence provides otherwise. The terms "resident"
and "nonresident" are defined differently for U.S. federal estate tax purposes than for U.S. federal income tax purposes.
Investors are urged to consult their own tax advisors regarding the U.S. federal estate tax consequences of the ownership or disposition
of our common stock.
Backup Withholding and Information
Reporting
Generally, we or certain financial middlemen
must report information to the IRS with respect to any dividends we pay on our common stock including the amount of any such dividends,
the name and address of the recipient, and the amount, if any, of tax withheld. A similar report is sent to the holder to whom
any such dividends are paid. Pursuant to tax treaties or certain other agreements, the IRS may make its reports available to tax
authorities in the recipient's country of residence.
Dividends paid by us (or our paying agents) to a Non-U.S. Holder
may also be subject to U.S. backup withholding. U.S. backup withholding generally will not apply to a Non-U.S. Holder who provides
a properly executed IRS Form W-8BEN or IRS Form W-8BEN-E, as applicable, or otherwise establishes an exemption, provided that the
applicable withholding agent does not have actual knowledge or reason to know the holder is a U.S. person.
Under current U.S. federal income tax law,
U.S. information reporting and backup withholding requirements generally will apply to the proceeds of a disposition of our common
stock effected by or through a U.S. office of any broker, U.S. or non-U.S., unless the Non-U.S. Holder provides a properly executed
IRS Form W-8BEN or IRS Form W-8BEN-E, as applicable, or otherwise meets documentary evidence requirements for establishing non-U.S.
person status or otherwise establishes an exemption. Generally, U.S. information reporting and backup withholding requirements
will not apply to a payment of disposition proceeds to a Non-U.S. Holder where the transaction is effected outside the United States
through a non-U.S. office of a non-U.S. broker. Information reporting and backup withholding requirements may, however, apply to
a payment of disposition proceeds if the broker has actual knowledge, or reason to know, that the holder is, in fact, a U.S. person.
For information reporting purposes, certain brokers with substantial U.S. ownership or operations will generally be treated in
a manner similar to U.S. brokers.
Backup withholding is not an additional
tax. If backup withholding is applied to you, you should consult with your own tax advisor to determine whether you have overpaid
your U.S. federal income tax, and whether you are able to obtain a tax refund or credit of the overpaid amount.
Foreign Accounts
In addition to, and separately from the
withholding rules described above, U.S. federal withholding taxes may apply under the Foreign Account Tax Compliance Act, or FATCA,
on certain types of payments, including dividends and, on or after January 1, 2019, the gross proceeds of a disposition of our
common stock, made to non-U.S. financial institutions and certain other non-U.S. entities. Specifically, a 30% withholding tax
may be imposed on dividends on, or gross proceeds from the sale or other disposition, on or after January 1, 2019, of, our common
stock paid to a "foreign financial institution" or a "non-financial foreign entity" (each as defined in the
Code), unless (1) the foreign financial institution agrees to undertake certain diligence and reporting obligations, (2) the non-financial
foreign entity either certifies it does not have any "substantial United States owners" (as defined in the Code) or furnishes
identifying information regarding each substantial United States owner, or (3) the foreign financial institution or non-financial
foreign entity otherwise qualifies for an exemption from these rules. The 30% federal withholding tax described in this paragraph
cannot be reduced under an income tax treaty with the United States. If the payee is a foreign financial institution and is subject
to the diligence and reporting requirements in (1) above, it must enter into an agreement with the U.S. Department of the Treasury
requiring, among other things, that it undertake to identify accounts held by certain "specified United States persons"
or "United States-owned foreign entities" (each as defined in the Code), annually report certain information about such
accounts, and withhold 30% on certain payments to non-compliant foreign financial institutions and certain other account holders.
Foreign financial institutions located in jurisdictions that have an intergovernmental agreement with the United States governing
FATCA may be subject to different rules.
Prospective investors should consult their
tax advisors regarding the potential application of withholding under FATCA to their investment in our common stock.
EACH PROSPECTIVE INVESTOR SHOULD CONSULT ITS OWN TAX ADVISOR
REGARDING THE TAX CONSEQUENCES OF PURCHASING, HOLDING AND DISPOSING OF OUR COMMON STOCK, INCLUDING THE CONSEQUENCES OF ANY PROPOSED
CHANGE IN APPLICABLE LAW, AS WELL AS TAX CONSEQUENCES ARISING UNDER ANY STATE, LOCAL, NON-U.S. OR U.S. FEDERAL NON-INCOME TAX LAWS
SUCH AS ESTATE AND GIFT TAX.
PLAN OF
DISTRIBUTION
We have entered into a distribution agreement
under which we may issue and sell our common stock having an aggregate sales price of up to $40,000,000 from time to time through
or to Raymond James as our sales agent. Sales of the our commons, if any, may be made by means of ordinary brokers’ transactions
on The Nasdaq Stock Market or otherwise at market prices, in block transactions or as otherwise agreed with Raymond James.
Raymond James, as sales agent, is not required
to sell any specific number or dollar amount of common stock but will use commercially reasonable efforts to solicit offers to
purchase the common stock upon entering into a transaction notice with us that will specify the number of common stock to be sold
and such other matters as may be agreed upon by us and Raymond James. Subject to the terms and conditions of the distribution agreement,
Raymond James will use commercially reasonable efforts to sell on our behalf all of the designated common stock pursuant to the
terms agreed to with us, which terms will include the number of common stock to be offered and any minimum price below which sales
may not be made. The obligation of Raymond James under the distribution agreement to sell shares pursuant to any transaction notice
is subject to a number of conditions, which Raymond James reserves the right to waive in its sole discretion.
Raymond James, in its capacity as sales
agent, may arrange for or make sales at the market in the existing trading market for our common stock, including sales made to
or through a market maker or through an electronic communications network, or in any other manner that may be deemed to be an “at-the-market”
offering as defined in Rule 415 promulgated under the Securities Act. If agreed to in a transaction notice, we may also sell
common stock to Raymond James as principal, at a purchase price agreed upon by Raymond James and us.
We will pay Raymond James a commission equal
to 2.5% of the gross sales price of any such shares sold through it as sales agent, or purchased by it as principal, as set forth
in the distribution agreement. The remaining sales proceeds, after deducting any transaction fees imposed by any governmental or
self-regulatory organization in connection with the sales, will equal our net proceeds for the sale of the common stock. Raymond
James shall be responsible for its own out-of-pocket expenses, including fees and expenses of counsel through the date of the distribution
agreement, as provided in the distribution agreement. We also have agreed to reimburse Raymond James for its out-of-pocket expenses,
up to $50,000 of fees and expenses, as provided in the distribution agreement.
Settlement for sales of common stock will
occur on the second business day following the date on which any sales are made in return for payment of the net proceeds to us.
There is no arrangement for funds to be received in an escrow, trust or similar arrangement. We will report at least quarterly
the number of common stock sold through Raymond James, as agent, in at-the-market offerings, the net proceeds to us and the compensation
paid by us to Raymond James in connection with such sales.
During the purchase date referenced in an
executed transaction notice, we will not (i) offer, pledge, announce the intention to sell, sell, contract to sell, sell any
option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase or otherwise
transfer or dispose of, directly or indirectly, any of our common stock or any securities convertible into or exercisable or exchangeable
for such shares or (ii) enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences
of ownership of such shares, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery
of common stock or such other securities, in cash or otherwise, without the prior written consent of Raymond James, other than
the shares to be sold pursuant to the distribution agreement and shares issued upon the exercise or conversion of any of our securities,
convertible securities, options or rights outstanding at the beginning of such period or any grants of options or awards or securities
issued pursuant to existing stock-based compensation plans.
NOTICE TO
INVESTORS
Notice to Investors in the United Kingdom
This prospectus supplement is only being
distributed to and is only directed at (i) persons outside the United Kingdom, (ii) investment professionals falling within Article
19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the ‘‘Order’’),
or (iii) high net worth companies, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to
(d) of the Order (all such persons in (i), (ii) and (iii) above together being referred to as ‘‘relevant persons’’).
The shares of our common stock are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise
acquire the shares of our common stock will be engaged in only with, relevant persons. Any person who is not a relevant person
should not act or rely on this prospectus supplement or any of the contents of such documents. Persons distributing this document
must satisfy themselves that it is lawful to do so.
In relation to anything to be done in the
United Kingdom:
|
|
·
|
this prospectus supplement has only been communicated and will only
be communicated in circumstances in which section 21(1) of the Financial Services and Markets Act 2000 (the ‘‘FSMA’’)
does not apply to Raymond James; and
|
|
|
·
|
each person involved in the issue of the shares of our common stock
has complied and will comply with all applicable provisions of the FSMA with respect to anything done by it in relation to the
shares of our common stock in, from or otherwise involving the United Kingdom.
|
European Economic Area
In relation to each Member State of the
European Economic Area which has implemented the Prospectus Directive (each, a ‘‘Relevant Member State’’),
an offer to the public of any shares of our common stock may not be made in that Relevant Member State except that an offer to
the public in that Relevant Member State of any shares of our common stock may be made (and this prospectus supplement), at any
time under the following exemptions under the Prospectus Directive:
|
|
·
|
to any legal entity which is a qualified investor as defined in the
Prospectus Directive;
|
|
|
·
|
to fewer than 150 natural or legal persons (other than qualified investors
as defined in the Prospectus Directive) subject to obtaining the prior consent of the relevant underwriters or underwriters nominated
by Raymond James for any such offer; or
|
|
|
·
|
in any other circumstances falling within Article 3(2) of the Prospectus
Directive,
|
provided that no such offer of the shares of our common stock
shall require Raymond James or any underwriter to publish a prospectus pursuant to Article 3 of the Prospectus Directive or supplement
a prospectus pursuant to Article 16 of the Prospectus Directive.
Each purchaser of the shares of our common
stock described in this prospectus supplement located in a Relevant Member State who receives any communication in respect of,
or who acquires any shares of our common stock under, this offering will be deemed to have represented, warranted and agreed with
each underwriter and Raymond James (i) it is a ‘‘qualified investor’’ within the meaning of Article 2(1)(e)
of the Prospectus Directive and (ii) in the case of any shares of our common stock acquired by it as a financial intermediary,
as that term is used in Article 3(2) of the Prospectus Directive, the shares of our common stock acquired by it in this offering
have not been acquired on behalf of, nor have they been acquired with a view to their offer or resale to, persons in any Relevant
Member State, other than qualified investors, as that term is defined in the Prospectus Directive, or in circumstances in which
the prior consent of the underwriters has been given to the offer or resale; or where the shares of our common stock have been
acquired by it on behalf of persons in any Relevant Member State other than qualified investors, the offer of the shares of our
common stock to it is not treated under the Prospectus Directive as having been made to such persons.
For the purposes of this provision, the
expression an ‘‘offer to the public’’ in relation to any shares of our common stock in any Relevant Member
State means the communication in any form and by any means of sufficient information on the terms of the offering and the shares
of our common stock to be offered so as to enable an investor to decide to purchase or subscribe for the shares of our common stock,
as the same may be varied in that Member State by any measure implementing the Prospectus Directive in that Member State, and the
expression ‘‘Prospectus Directive’’ means Directive 2003/71/EC (as amended, including by Directive 2010/73/EU)
and includes any relevant implementing measure in each Relevant Member State.
Legal Matters
Fenwick & West, LLP, Mountain View,
California, will pass upon certain legal matters relating to this offering. Morrison & Foerster LLP, New York, New York, is
acting as counsel to the sales agent in connection with this offering.
Experts
The financial statements as of December
31, 2016 and 2015 and for each of the two years in the period ended December 31, 2016 incorporated by reference in this prospectus
supplement have been so incorporated in reliance on the reports of Marcum LLP, an independent registered public accounting firm,
incorporated herein by reference, given on the authority of said firm as experts in auditing and accounting.
Where You
Can Find More Information
We are subject to the information requirements
of the Exchange Act, and in accordance therewith, file periodic reports, proxy statements and other information with the SEC. We
also filed a registration statement on Form S-3, including exhibits, under the Securities Act, with respect to the securities offered
by this prospectus supplement. This prospectus supplement and the accompanying prospectus are a part of the registration statement
but do not contain all of the information included in the registration statement or the exhibits. You may read and copy the registration
statement, and any other document that we file, at the SEC’s public reference room at 100 F Street, N.E., Washington, D.C.
20549. You can call the SEC at 1-800-SEC-0330 for further information on the operation of the public reference room. You can also
find our public filings with the SEC on the internet at a website maintained by the SEC located at www.sec.gov.
Incorporation
of Certain Information by Reference
The SEC allows us to “incorporate by
reference” information into this prospectus supplement and the accompanying prospectus, which means that we can disclose
important information about us by referring you to another document filed separately with the SEC. The information incorporated
by reference is considered to be a part of this prospectus supplement and the accompanying prospectus. We incorporate by reference
the documents and reports listed below (other than Current Reports on Form 8-K furnished under Item 2.02 or Item 7.01 and exhibits
filed on such form that are related to such items):
|
|
·
|
our Annual Report on Form 10-K for the fiscal year ended December
31, 2016, filed with the SEC on March 16, 2017;
|
|
|
·
|
our Quarterly Reports on Form 10-Q for the quarters ended March 31,
2017 (filed with the SEC on May 10, 2017), June 30, 2017 (filed with the SEC on August 9, 2017) and September 30, 2017 (filed with
the SEC on November 9, 2017);
|
|
|
·
|
our Current Reports on Form 8-K filed on January 3, 2017, May 19,
2017, June 29, 2017; December 27, 2017; January 11, 2018 and January 12, 2018;
|
|
|
·
|
the description of our common stock contained in our Registration
Statement on Form 8-A, filed with the SEC pursuant to Section 12(g) of the Exchange Act on March 26, 2014, including any further
amendment or report filed hereafter for the purpose of updating such description; and
|
|
|
·
|
all documents filed after the date of this prospectus supplement and
prior to the termination of the offering hereunder pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act
of 1934.
|
Information in this prospectus supplement
supersedes related information in the documents listed above, and information in subsequently filed documents supersedes related
information in each of this prospectus supplement, the prospectus and the incorporated documents.
We will promptly provide, without charge
to you, upon written or oral request, a copy of any or all of the documents incorporated by reference in this prospectus supplement
or the prospectus, other than exhibits to those documents, unless the exhibits are specifically incorporated by reference in those
documents. Requests should be directed to:
Corporate Secretary
Energous Corporation
3590 North First Street, Suite 210
San Jose, California 95134
(408) 963-0200
You can also find these filings on our website at
www.energous.com
.
We are not incorporating the information on our website other than these filings into this prospectus supplement or the prospectus.
The information in this
prospectus is not complete and may be changed. the securities may not be sold until the registration statement filed with the
Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting
an offer to buy these securities in any state where the offer or sale is not permitted.
SUBJECT TO COMPLETION, DATED APRIL
24,
2015
ENERGOUS CORPORATION
$75,000,000
Common Stock
Preferred Stock
Debt Securities
Warrants
This prospectus relates to common stock, preferred
stock, debt securities and warrants that we may sell from time to time in one or more offerings up to a total public offering
price of $75,000,000 on terms to be determined at the time of sale. We will provide specific terms of these securities in supplements
to this prospectus. You should read this prospectus and any supplement carefully before you invest. This prospectus may not be
used to offer and sell securities unless accompanied by a prospectus supplement for those securities.
Our common stock trades on the NASDAQ Capital
Market under the symbol “WATT.”
These securities may be sold directly by us,
through dealers or agents designated from time to time, to or through underwriters or through a combination of these methods.
See “Plan of Distribution” in this prospectus. We may also describe the plan of distribution for any particular offering
of these securities in any applicable prospectus supplement. If any agents, underwriters or dealers are involved in the sale of
any securities in respect of which this prospectus is being delivered, we will disclose their names and the nature of our arrangements
with them in a prospectus supplement. The net proceeds we expect to receive from any such sale will also be included in a prospectus
supplement.
Neither the Securities and Exchange Commission
nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of
this prospectus. Any representation to the contrary is a criminal offense.
The date of this prospectus
is
[•], 2015
.
Table of Contents
WHERE
YOU CAN FIND MORE INFORMATION
We file annual, quarterly and special reports,
proxy statements and other information with the Securities and Exchange Commission (the “SEC”). You can inspect and
copy these reports, proxy statements and other information at the SEC’s Public Reference Room at 100 F Street, N.E., Washington,
D. C. 20549. Please call the SEC at 1-800-SEC-0330 for further information on the Public Reference Room. The SEC also maintains
a web site that contains reports, proxy and information statements and other information regarding issuers, such as Energous Corporation
(www.sec.gov). Our web site is located at www.energous.com. The information contained on our web site is not part of this prospectus.
This prospectus “incorporates by reference”
certain information that we have filed with the SEC under the Securities Exchange Act of 1934. This means we are disclosing important
information to you by referring you to those documents. We incorporate by reference the documents listed below and any future
filings made by us with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act until the offering is terminated:
|
|
·
|
Annual Report
on Form 10-K for the fiscal year ended December 31, 2014 as filed on March 30, 2015;
|
|
|
·
|
The information
specifically incorporated by reference into our Annual Report on Form 10-K for the year
ended December 31, 2014 from our definitive proxy statement on Schedule 14A, as filed
on April 17, 2015;
|
|
|
·
|
Current Report
on Form 8-K filed on April 9, 2015 (other than the portions of those documents furnished
but deemed not to have been filed); and
|
|
|
·
|
The description
of the Company’s Common Stock contained in the Company’s Registration Statement
on Form 8-A, filed with the SEC pursuant to Section 12(g) of the Exchange Act on March
26, 2014, including any further amendment or report filed hereafter for the purpose of
updating such description.
|
You should rely only on the information incorporated
by reference or provided in this prospectus. We have authorized no one to provide you with different information. You should not
assume that the information in this prospectus is accurate as of any date other than the date on the front of this document. All
documents that we file subsequently pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act and prior to the termination
or completion of the offering (including all such documents that we may file with the SEC after the date of the initial registration
statement and prior to the effectiveness of the registration statement) will be deemed to be incorporated in this prospectus by
reference and will be a part of this prospectus from the date of the filing of the document. Any statement contained in a document
incorporated or deemed to be incorporated by reference in this prospectus will be deemed to be modified or superseded for purposes
of this prospectus to the extent that a statement contained in this prospectus or in any other subsequently filed document which
also is or is deemed to be incorporated by reference in this prospectus modifies or supersedes that statement. Any statement that
is modified or superseded will not constitute a part of this prospectus, except as modified or superseded.
We will provide, upon written or oral request,
without charge to you, including any beneficial owner to whom this prospectus is delivered, a copy of any or all of the documents
incorporated herein by reference other than the exhibits to those documents, unless the exhibits are specifically incorporated
by reference into the information that this prospectus incorporates. You should direct a request for copies to us at Attention:
Secretary, 3590 North First Street, Suite 210, San Jose, CA 95134 or you may call us at (408) 963-0200.
FORWARD-LOOKING
STATEMENTS
Certain information set forth in this prospectus
or incorporated by reference in this prospectus may contain forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934,
as amended (the “Exchange Act”), that are intended to be covered by the “safe harbor” created by those
sections. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations,
can generally be identified by the use of forward-looking terms such as “believe,” “expect,” “may,”
“will,” “should,” “would,” “could,” “seek,” “intend,”
“plan,” “estimate,” “goal,” “anticipate,” “project” or other comparable
terms. Forward-looking statements involve inherent risks and uncertainties which could cause actual results to differ materially
from those in the forward-looking statements, as a result of various factors including those risks and uncertainties included
in this prospectus under the caption “Risk Factors,” and those risks and uncertainties described in the documents
incorporated by reference into this prospectus. We urge you to consider those risks and uncertainties in evaluating our forward-looking
statements. All subsequent written and oral forward-looking statements attributable to us or to persons acting on our behalf are
expressly qualified in their entirety by the applicable cautionary statements. We further caution readers not to place undue reliance
upon any such forward-looking statements, which speak only as of the date made. Except as otherwise required by the federal securities
laws, we disclaim any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement
contained herein or in the accompanying prospectus (or elsewhere) to reflect any change in our expectations with regard thereto
or any change in events, conditions or circumstances on which any such statement is based.
PROSPECTUS
SUMMARY
This prospectus is part of a registration statement
on Form S-3 that we filed with the SEC utilizing a “shelf” registration process. Under this shelf process, we may
from time to time, sell any combination of securities described in this prospectus in one or more offerings.
This prospectus provides you with a general
description of the securities we may offer. Each time we sell securities, we will provide a prospectus supplement that will contain
specific information about the terms of the securities being offered. That prospectus supplement may include a discussion of any
risk factors or other special consideration that apply to those securities. The prospectus supplement may also add, update or
change information contained in this prospectus. If there is any inconsistency between the information in this prospectus and
a prospectus supplement, you should rely on the information in that prospectus supplement. You should read both this prospectus
and any applicable prospectus supplement together with additional information described above under the heading “Where You
Can Find More Information.”
When acquiring any securities discussed in
this prospectus, you should rely on the information provided in this prospectus and the prospectus supplement, including the information
incorporated by reference. Neither we, nor any underwriters or agents, have authorized anyone to provide you with different information.
We are not offering the securities in any state where such an offer is prohibited. You should not assume that the information
in this prospectus, any prospectus supplement, or any document incorporated by reference, is truthful or complete at any date
other than the date mentioned on the cover page of those documents. You should also carefully review the section entitled “Risk
Factors”, which highlights certain risks associated with an investment in our securities, to determine whether an investment
in our securities is appropriate for you.
References in this prospectus
to “Energous”, the “Company”, “we”, “us” and “our” are to Energous
Corporation.
THE
COMPANY
Overview
We are developing technology that can enable
wire-free charging for electronic devices that provides power at a distance with mobility under full software control. Our ultimate
goal is to license our WattUp
TM
technology to consumer product companies, device manufacturers, wireless data router
manufacturers and other commercial partners to make wire-free charging an affordable, ubiquitous and convenient service offering
for end users. We believe our proprietary technology can potentially be used in a variety of devices, including smart phones, tablets,
e-book readers, wearables, keyboards, mice, remote controls, rechargeable lights and any other devices with similar charging requirements
that would otherwise need a battery or a connection to a power outlet.
We believe our technology is novel in its
approach, in that it charges devices by surrounding them with a radio frequency (“RF”) pocket (“RF pocket”).
We are developing solutions that enable wire-free transmission of energy from one or multiple transmitter(s) to multiple receivers
connected to or integrated into electronic devices, at distances of up to fifteen (15) feet. We have developed multiple prototype
systems consisting of either a single or multiple transmitter(s) in various forms and sizes, multiple smart phone receiver cases,
various other forms of receiving devices and management software.
We are also developing what we believe will
be an enterprise class management and control system for our WattUp solution that will incorporate cloud based network management
as well as the necessary local interface and control for the transmitter and receiver.
We believe that if our development, regulatory
and commercialization efforts are successful, our transmitter and receiver solutions will initially be able to simultaneously charge
multiple mobile consumer electronic devices, at varying charging levels, depending on the number of devices, with a range of fifteen
(15) feet in radius or in a charging envelop bounded by thirty (30) feet. Subsequent development efforts will focus on increasing
the power delivery capability, increasing distance, enhancing the management and control solution and lowering overall system cost.
As part of our commercialization efforts,
in May 2014 we executed our first of 16 joint development agreements with strategic partners which provide for the review of our
technology and which serve to describe the integration of our technology into the strategic partners’ products. At the Consumer
Electronics Show, January 5-9, 2015, we met with over 100 existing or new potential joint development partners and investors, and
demonstrated whole house charging coverage through the use of WattUp technology through multiple transmitters packaged in a variety
of consumer friendly form factors, including televisions, bed-side units, sound bars, wall units and speakers. It is our objective
during 2015 to narrow our research and development efforts to those strategic partners whose goals, capabilities and commercialization
potential most closely aligns with ours.
In January 2015, we signed a development
and licensing agreement with a tier-one consumer electronics company to embed WattUp wire-free charging receiver technology in
various products including, but not limited to mobile consumer electronics and related accessories. During the development phase
and through customer shipment of the first licensed product, we will afford this customer a time to market advantage in the licensed
product categories.
This development and licensing agreement
contains both invention and development milestones that we will need to achieve during the next two years. Pursuant to the Agreement,
we will receive development payments based upon our achievement of milestones, as provided for in the Agreement, including the
receipt of an initial non-refundable payment of $500,000. There can be no assurance that we will meet all required milestones under
this agreement or that this strategic partner will include our technology in any products.
We have pursued an aggressive intellectual
property strategy and are developing new patents. As of December 31, 2014, we had in excess of 125 pending U.S. patents and provisional
patent applications. In addition to the inventions covered by these patent applications, we have identified a significant number
of additional specific inventions we believe may be novel and patentable. We intend to file for patent protection for the most
valuable of these, as well as for other new inventions that we expect to develop. Our strategy is to continually monitor the costs
and benefits of each patent application and, when appropriate, pursue those that will best protect our business.
We have recruited and hired a seasoned management
team with public company and relevant industry experience to develop and execute our operating plan. In addition, we have identified
and hired additional engineering resources, which we expect will build up the engineering capability of our internal team. We were
incorporated in Delaware on October 30, 2012 under the name DvineWave Inc. and in January 2014 we changed our name to Energous
Corporation. We are located in San Jose, CA. To date, our operations have been funded through the sale of our common stock and
convertible debt (which has since been converted into shares of our common stock).
Through December 31, 2014, we had not generated revenue, and
have incurred significant losses from operations. We expect to continue to incur operating losses for the foreseeable future as
we develop our technology.
Status as an Emerging Growth Company
We are an “emerging growth company”
as that term is defined in the Jumpstart Our Business Startups Act (the “JOBS Act”). Section 102(b)(1) of the JOBS
Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private
companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class
of securities registered under the Securities Exchange Act) are required to comply with the new or revised financial accounting
standard. The JOBS Act also provides that a company can elect to opt out of the extended transition period provided by Section
102(b)(1) of the JOBS Act and comply with the requirements that apply to non-emerging growth companies but any such election to
opt out is irrevocable. We have irrevocably elected to opt out of this extended transition period provided by Section 102(b)(1)
of the JOBS Act. Even though we have elected to opt out of the extended transition period, we may still take advantage of all
of the other provisions of the JOBS Act, which include, but are not limited to, not being required to comply with the auditor
attestation requirements of Section 404 of the Sarbanes-Oxley Act, the reduced disclosure obligations regarding executive compensation
in our periodic reports and proxy statements and the exemptions from the requirements of holding a nonbinding advisory vote on
executive compensation and stockholder approval of any golden parachute payments not previously approved.
USE
OF PROCEEDS
We currently intend to use the estimated net
proceeds from the sale of these securities for general corporate and working capital purposes, including to fund strategic initiatives
that we may undertake from time to time and for product development. We have not yet determined the amount of net proceeds to
be used specifically for any of the foregoing purposes. Accordingly, our management will have significant discretion and flexibility
in applying the net proceeds from the sale of these securities. Our plans to use the estimated net proceeds from the sale of these
securities may change, and if they do, we will update this information in a prospectus supplement.
RISK
FACTORS
Investing in our securities involves risk.
See the risk factors described in our Annual Report on Form 10-K for our most recent fiscal year (together with any material changes
thereto contained in subsequent filed Quarterly Reports on Form 10-Q) and those contained in our other filings with the SEC, which
are incorporated by reference in this prospectus and any accompanying prospectus supplement.
The prospectus supplement applicable to each
type or series of securities we offer may contain a discussion of risks applicable to the particular types of securities that
we are offering under that prospectus supplement. Prior to making a decision about investing in our securities, you should carefully
consider the specific factors discussed under the caption “Risk Factors” in the applicable prospectus supplement,
together with all of the other information contained in the prospectus supplement or appearing or incorporated by reference in
this prospectus. These risks could materially affect our business, results of operations or financial condition and cause the
value of our securities to decline. You could lose all or part of your investment.
DESCRIPTION
OF DEBT SECURITIES WE MAY OFFER
We may sell the securities being offered pursuant
to this prospectus directly to purchasers, to or through underwriters, through dealers or agents, or through a combination of
such methods. The prospectus supplement with respect to the securities being offered will set forth the terms of the offering
of those securities, including the names of the underwriters, dealers or agents, if any, the purchase price, the net proceeds
to us, any underwriting discounts and other items constituting underwriters’ compensation, the initial public offering price,
any discounts or concessions allowed or reallowed or paid to dealers and any securities exchanges on which such securities may
be listed.
General
The debt securities that we may issue will
constitute debentures, notes, bonds or other evidences of indebtedness of Energous, to be issued in one or more series, which
may include senior debt securities, subordinated debt securities and senior subordinated debt securities. The particular terms
of any series of debt securities we offer, including the extent to which the general terms set forth below may be applicable to
a particular series, will be described in a prospectus supplement relating to such series.
Debt securities that we may issue will be issued
under an indenture between us and a trustee qualified to act as such under the Trust Indenture Act of 1939. We have filed the
form of the indenture as an exhibit to the registration statement of which this prospectus is a part. When we refer to the “indenture”
in this prospectus, we are referring to the indenture under which your debt securities are issued as supplemented by any supplemental
indenture applicable to your debt securities. We will provide the name of the trustee in any prospectus supplement related to
the issuance of debt securities, and we will also provide certain other information related to the trustee, including describing
any relationship we have with the trustee, in such prospectus supplement.
THE FOLLOWING DESCRIPTION IS A SUMMARY OF THE
MATERIAL PROVISIONS OF THE INDENTURE. IT DOES NOT RESTATE THE INDENTURE IN ITS ENTIRETY. THE INDENTURE IS GOVERNED BY THE TRUST
INDENTURE ACT OF 1939. THE TERMS OF THE DEBT SECURITIES INCLUDE THOSE STATED IN THE INDENTURE AND THOSE MADE PART OF THE INDENTURE
BY REFERENCE TO THE TRUST INDENTURE ACT. WE URGE YOU TO READ THE INDENTURE BECAUSE IT, AND NOT THIS DESCRIPTION, DEFINES YOUR
RIGHTS AS A HOLDER OF THE DEBT SECURITIES.
Information You Will
Find In The Prospectus Supplement
The indenture provides that we may issue debt
securities from time to time in one or more series and that we may denominate the debt securities and make them payable in foreign
currencies. The indenture does not limit the aggregate principal amount of debt securities that can be issued thereunder. The
prospectus supplement for a series of debt securities will provide information relating to the terms of the series of debt securities
being offered, which may include:
|
|
·
|
the title and
denominations of the debt securities of the series;
|
|
|
·
|
any limit on
the aggregate principal amount of the debt securities of the series;
|
|
|
·
|
the date or
dates on which the principal and premium, if any, with respect to the debt securities
of the series are payable or the method of determination thereof;
|
|
|
·
|
the rate or
rates, which may be fixed or variable, at which the debt securities of the series shall
bear interest, if any, or the method of calculating and/or resetting such rate or rates
of interest;
|
|
|
·
|
the dates from
which such interest shall accrue or the method by which such dates shall be determined
and the duration of the extensions and the basis upon which interest shall be calculated;
|
|
|
·
|
the interest
payment dates for the series of debt securities or the method by which such dates will
be determined, the terms of any deferral of interest and any right of ours to extend
the interest payments periods;
|
|
|
·
|
the place or
places where the principal and interest on the series of debt securities will be payable;
|
|
|
·
|
the terms and
conditions upon which debt securities of the series may be redeemed, in whole or in part,
at our option or otherwise;
|
|
|
·
|
our obligation,
if any, to redeem, purchase, or repay debt securities of the series pursuant to any sinking
fund or other specified event or at the option of the holders and the terms of any such
redemption, purchase, or repayment;
|
|
|
·
|
the terms, if
any, upon which the debt securities of the series may be convertible into or exchanged
for other securities, including, among other things, the initial conversion or exchange
price or rate and the conversion or exchange period;
|
|
|
·
|
if the amount
of principal, premium, if any, or interest with respect to the debt securities of the
series may be determined with reference to an index or formula, the manner in which such
amounts will be determined;
|
|
|
·
|
if any payments
on the debt securities of the series are to be made in a currency or currencies (or by
reference to an index or formula) other than that in which such securities are denominated
or designated to be payable, the currency or currencies (or index or formula) in which
such payments are to be made and the terms and conditions of such payments;
|
|
|
·
|
any changes
or additions to the provisions of the indenture dealing with defeasance, including any
additional covenants that may be subject to our covenant defeasance option;
|
|
|
·
|
the currency
or currencies in which payment of the principal and premium, if any, and interest with
respect to debt securities of the series will be payable, or in which the debt securities
of the series shall be denominated, and the particular provisions applicable thereto
in accordance with the indenture;
|
|
|
·
|
the portion
of the principal amount of debt securities of the series which will be payable upon declaration
of acceleration or provable in bankruptcy or the method by which such portion or amount
shall be determined;
|
|
|
·
|
whether the
debt securities of the series will be secured or guaranteed and, if so, on what terms;
|
|
|
·
|
any addition
to or change in the events of default with respect to the debt securities of the series;
|
|
|
·
|
the identity
of any trustees, authenticating or paying agents, transfer agents or registrars;
|
|
|
·
|
the applicability
of, and any addition to or change in, the covenants currently set forth in the indenture;
|
|
|
·
|
the subordination,
ranking or priority, if any, of the debt securities of the series and terms of the subordination;
|
|
|
·
|
any other terms
of the debt securities of the series which are not prohibited by the indenture; and
|
|
|
·
|
whether securities
of the series shall be issuable as registered securities or bearer securities (with or
without interest coupons), and any restrictions applicable to the offering, sale or delivery
of such bearer securities and the terms upon which such bearer securities of a series
may be exchanged for registered securities, and vice versa.
|
Holders of debt securities may present debt
securities for exchange in the manner, at the places, and subject to the restrictions set forth in the debt securities, the indenture,
and the prospectus supplement. We will provide these services without charge, other than any tax or other governmental charge
payable in connection therewith, but subject to the limitations provided in the indenture, any board resolution establishing such
debt securities and any applicable indenture supplement. Debt securities in bearer form and the coupons, if any, appertaining
thereto will be transferable by delivery.
Senior Debt
We may issue senior debt securities under the
indenture and any coupons that will constitute part of our senior debt. Unless otherwise set forth in the applicable indenture
supplement and described in a prospectus supplement, the senior debt securities will be senior unsecured obligations, ranking
equally with all of our existing and future senior unsecured debt. The senior debt securities will be senior to all of our subordinated
debt and junior to any secured debt we may incur as to the assets securing such debt.
Subordinated Debt
We may issue subordinated debt securities under
the indenture and any coupons that will constitute part of such subordinated debt. These subordinated debt securities will be
subordinate and junior in right of payment, to the extent and in the manner set forth in the indenture and any applicable indenture
supplement, to all of our senior indebtedness.
If this prospectus is being delivered in connection
with a series of subordinated debt securities, the accompanying prospectus supplement or the information incorporated by reference
will set forth the approximate amount of senior indebtedness outstanding as of the end of the most recent fiscal quarter.
Senior Subordinated Debt
We may issue senior subordinated debt securities
under the indenture and any coupons that will constitute part of our senior subordinated debt. These senior subordinated debt
securities will be, to the extent and in the manner set forth in the applicable indenture supplement, subordinate and junior in
right of payment to all of our “senior indebtedness” and senior to our other subordinated debt. See the discussions
above under “—Senior Debt” and “—Subordinated Debt” for a more detailed explanation of our
senior and subordinated indebtedness.
Interest Rate
Debt securities that bear interest will do
so at a fixed rate or a floating rate. We may sell, at a discount below the stated principal amount, any debt securities which
bear no interest or which bear interest at a rate that at the time of issuance is below the prevailing market rate. The relevant
prospectus supplement will describe the special United States federal income tax considerations applicable to:
|
|
·
|
any discounted
debt securities; and
|
|
|
·
|
any debt securities
issued at par which are treated as having been issued at a discount for United States
federal income tax purposes.
|
Registered Global Securities
We may issue registered debt securities of
a series in the form of one or more fully registered global securities. We will deposit the registered global security with a
depository or with a nominee for a depository identified in the prospectus supplement relating to such series. The global security
or global securities will represent and will be in a denomination or aggregate denominations equal to the portion of the aggregate
principal amount of outstanding registered debt securities of the series to be represented by the registered global security or
securities. Unless it is exchanged in whole or in part for debt securities in definitive registered form, a registered global
security may not be transferred, except as a whole in three cases:
|
|
·
|
by the depository
for the registered global security to a nominee of the depository;
|
|
|
·
|
by a nominee
of the depository to the depository or another nominee of the depository; and
|
|
|
·
|
by the depository
or any nominee to a successor of the depository or a nominee of the successor.
|
The prospectus supplement relating to a series
of debt securities will describe the specific terms of the depository arrangement concerning any portion of that series of debt
securities to be represented by a registered global security. We anticipate that the following provisions will generally apply
to all depository arrangements.
Upon the issuance of a registered global security,
the depository will credit, on its book-entry registration and transfer system, the principal amounts of the debt securities represented
by the registered global security to the accounts of persons that have accounts with the depository. These persons are referred
to as “participants.” Any underwriters, agents or debtors participating in the distribution of debt securities represented
by the registered global security will designate the accounts to be credited. Only participants or persons that hold interests
through participants will be able to beneficially own interests in a registered global security. The depository for a global security
will maintain records of beneficial ownership interests in a registered global security for participants. Participants or persons
that hold through participants will maintain records of beneficial ownership interests in a global security for persons other
than participants. These records will be the only means to transfer beneficial ownership in a registered global security.
The laws of some states may require that specified
purchasers of securities take physical delivery of the securities in definitive form. These laws may limit the ability of those
persons to own, transfer or pledge beneficial interests in global securities.
So long as the depository, or its nominee,
is the registered owner of a registered global security, the depository or its nominee will be considered the sole owner or holder
of the debt securities represented by the registered global security for all purposes under the indenture. Except as set forth
below, owners of beneficial interests in a registered global security:
|
|
·
|
may not have
the debt securities represented by a registered global security registered in their names;
|
|
|
·
|
will not receive
or be entitled to receive physical delivery of debt securities represented by a registered
global security in definitive form; and
|
|
|
·
|
will not be
considered the owners or holders of debt securities represented by a registered global
security under the indenture.
|
Accordingly, each person owning a beneficial
interest in a registered global security must rely on the procedures of the depository for the registered global security and,
if the person is not a participant, on the procedures of the participant through which the person owns its interests, to exercise
any rights of a holder under the indenture applicable to the registered global security.
We understand that, under existing industry
practices, if we request any action of holders, or if an owner of a beneficial interest in a registered global security desires
to give or take any action which a holder is entitled to give or take under the indenture, the depository for the registered global
security would authorize the participants holding the relevant beneficial interests to give or take the action, and the participants
would authorize beneficial owners owning through the participants to give or take the action or would otherwise act upon the instructions
of beneficial owners holding through them.
Payment of Interest on
and Principal of Registered Global Securities
We will make principal, premium, if any, and
interest payments on debt securities represented by a registered global security registered in the name of a depository or its
nominee to the depository or its nominee as the registered owner of the registered global security. None of Energous, the trustee,
or any paying agent for debt securities represented by a registered global security will have any responsibility or liability
for:
|
|
·
|
any aspect of
the records relating to, or payments made on account of, beneficial ownership interests
in such registered global security;
|
|
|
·
|
maintaining,
supervising, or reviewing any records relating to beneficial ownership interests;
|
|
|
·
|
the payments
to beneficial owners of the global security of amounts paid to the depository or its
nominee; or
|
|
|
·
|
any other matter
relating to the actions and practices of the depository, its nominee or any of its participants.
|
We expect that the depository, upon receipt
of any payment of principal, premium or interest in respect of the global security, will immediately credit participants’
accounts with payments in amounts proportionate to their beneficial interests in the principal amount of a registered global security
as shown on the depository’s records. We also expect that payments by participants to owners of beneficial interests in
a registered global security held through participants will be governed by standing instructions and customary practices. This
is currently the case with the securities held for the accounts of customers registered in “street name.” Such payments
will be the responsibility of participants.
Exchange of Registered
Global Securities
We may issue debt securities in definitive
form in exchange for the registered global security if both of the following occur:
|
|
·
|
the depository
for any debt securities represented by a registered global security is at any time unwilling
or unable to continue as depository or ceases to be a clearing agency registered under
the Exchange Act; and
|
|
|
·
|
we do not appoint
a successor depository within 90 days.
|
In addition, we may, at any time, determine
not to have any of the debt securities of a series represented by one or more registered global securities. In this event, we
will issue debt securities of that series in definitive form in exchange for all of the registered global security or securities
representing those debt securities.
Covenants by Energous
The indenture includes covenants by us, including
among other things that we will make all payments of principal and interest at the times and places required. The supplemental
indenture establishing each series of debt securities may contain additional covenants, including covenants which could restrict
our right to incur additional indebtedness or liens and to take certain actions with respect to our businesses and assets.
Events of Default
Unless otherwise indicated in the applicable
prospectus supplement, the following will be events of default under the indenture with respect to each series of debt securities
issued under the indenture:
|
|
·
|
failure to pay
when due any interest on any debt security of that series, continued for 30 days;
|
|
|
·
|
failure to pay
when due the principal of, or premium, if any, on, any debt security of that series;
|
|
|
·
|
default in the
payment of any sinking fund installment with respect to any debt security of that series
when due and payable;
|
|
|
·
|
failure to perform
any other covenant or agreement of ours under the indenture or the supplemental indenture
with respect to that series or the debt securities of that series, continued for 90 days
after written notice to us by the trustee or holders of at least 25% in aggregate principal
amount of the outstanding debt securities of the series to which the covenant or agreement
relates;
|
|
|
·
|
certain events
of bankruptcy, insolvency or similar proceedings affecting us; and
|
|
|
·
|
any other event
of default specified in any supplemental indenture under which such series of debt securities
is issued.
|
Except as to certain events of bankruptcy,
insolvency or similar proceedings affecting us and except as provided in the applicable prospectus supplement, if any event of
default shall occur and be continuing with respect to any series of debt securities under the indenture, either the trustee or
the holders of at least 25% in aggregate principal amount of outstanding debt securities of such series may accelerate the maturity
of all debt securities of such series. Upon certain events of bankruptcy, insolvency or similar proceedings affecting us, the
principal, premium, if any, and interest on all debt securities of each series shall be immediately due and payable.
After any such acceleration, but before a judgment
or decree based on acceleration has been obtained by the trustee, the holders of a majority in aggregate principal amount of each
affected series of debt securities may waive all defaults with respect to such series and rescind and annul such acceleration
if all events of default, other than the non-payment of accelerated principal, have been cured, waived or otherwise remedied.
No holder of any debt securities will have
any right to institute any proceeding with respect to the indenture or for any remedy under the indenture, unless such holder
shall have previously given to the trustee written notice of a continuing event of default and the holders of at least 25% in
aggregate principal amount of the outstanding debt securities of the relevant series shall have made written request and offered
indemnity satisfactory to the trustee to institute such proceeding as trustee, and the trustee shall not have received from the
holders of a majority in aggregate principal amount of the outstanding debt securities of such series a direction inconsistent
with such request and shall have failed to institute such proceeding within 60 days. However, such limitations do not apply
to a suit instituted by a holder of a debt security for enforcement of payment of the principal of and premium, if any, or interest
on such debt security on or after the respective due dates expressed in such debt security.
Supplemental Indentures
We and the trustee may, at any time and from
time to time, without prior notice to or consent of any holders of debt securities, enter into one or more indentures supplemental
to the indenture, among other things:
|
|
·
|
to add guarantees
to or secure any series of debt securities;
|
|
|
·
|
to provide for
the succession of another person pursuant to the provisions of the indenture relating
to consolidations, mergers and sales of assets and the assumption by such successor of
our covenants, agreements, and obligations, or to otherwise comply with the provisions
of the indenture relating to consolidations, mergers, and sales of assets;
|
|
|
·
|
to surrender
any right or power conferred upon us under the indenture or to add to our covenants further
covenants, restrictions, conditions or provisions for the protection of the holders of
all or any series of debt securities;
|
|
|
·
|
to cure any
ambiguity or to correct or supplement any provision contained in the indenture, in any
supplemental indenture or in any debt securities that may be defective or inconsistent
with any other provision contained therein;
|
|
|
·
|
to modify or
amend the indenture in such a manner as to permit the qualification of the indenture
or any supplemental indenture under the Trust Indenture Act;
|
|
|
·
|
to add to or
change any of the provisions of the indenture to supplement any of the provisions of
the indenture in order to permit the defeasance and discharge of any series of debt securities
pursuant to the indenture, so long as any such action does not adversely affect the interests
of the holders of debt securities of any series in any material respect;
|
|
|
·
|
to add to, change,
or eliminate any of the provisions of the indenture with respect to one or more series
of debt securities, so long as any such addition, change or elimination shall not apply
to any debt securities of any series created prior to the execution of such supplemental
indenture and entitled to the benefit of such provision;
|
|
|
·
|
to evidence
and provide for the acceptance of appointment by a successor or separate trustee; and
|
|
|
·
|
to establish
the form or terms of debt securities of any series and to make any change that does not
adversely affect the interests of the holders of debt securities.
|
With the consent of the holders of at least
a majority in principal amount of debt securities of each series affected by such supplemental indenture (each series voting as
one class), we and the trustee may enter into one or more supplemental indentures for the purpose of adding any provisions to
or changing in any manner or eliminating any of the provisions of the indenture or modifying in any manner the rights of the holders
of debt securities of each such series.
Notwithstanding our rights and the rights of
the trustee to enter into one or more supplemental indentures with the consent of the holders of debt securities of the affected
series as described above, no such supplemental indenture shall, without the consent of the holder of each outstanding debt security
of the affected series, among other things:
|
|
·
|
change the final
maturity of the principal of, or any installment of interest on, any debt securities;
|
|
|
·
|
reduce the principal
amount of any debt securities or the rate of interest on any debt securities;
|
|
|
·
|
change the currency
in which any debt securities are payable;
|
|
|
·
|
impair the right
of the holders to conduct a proceeding for any remedy available to the trustee;
|
|
|
·
|
reduce the percentage
in principal amount of any series of debt securities whose holders must consent to an
amendment or supplemental indenture;
|
|
|
·
|
modify the ranking
or priority of the securities;
|
|
|
·
|
reduce any premium
payable upon the redemption of any debt securities; or
|
|
|
·
|
make any change
that adversely affects the relative rights of holders of subordinated debt securities
with respect to senior debt securities.
|
Satisfaction and Discharge
of the Indenture; Defeasance
Except to the extent set forth in a supplemental
indenture with respect to any series of debt securities, we, at our election, may discharge the indenture and the indenture shall
generally cease to be of any further effect with respect to that series of debt securities if (a) we have delivered to the
trustee for cancellation all debt securities of that series (with certain limited exceptions) or (b) all debt securities
of that series not previously delivered to the trustee for cancellation shall have become due and payable, or are by their terms
to become due and payable within one year or are to be called for redemption within one year, and we have deposited with the trustee
the entire amount sufficient to pay at maturity or upon redemption all such debt securities.
In addition, we have a “legal defeasance
option” (pursuant to which we may terminate, with respect to the debt securities of a particular series, all of our obligations
under such debt securities and the indenture with respect to such debt securities) and a “covenant defeasance option”
(pursuant to which we may terminate, with respect to the debt securities of a particular series, our obligations with respect
to such debt securities under certain specified covenants contained in the indenture). If we exercise our legal defeasance option
with respect to a series of debt securities, payment of such debt securities may not be accelerated because of an event of default.
If we exercise our covenant defeasance option with respect to a series of debt securities, payment of such debt securities may
not be accelerated because of an event of default related to the specified covenants.
We may exercise our legal defeasance option
or our covenant defeasance option with respect to the debt securities of a series only if we irrevocably deposit in trust with
the trustee cash or U.S. government obligations (as defined in the indenture) for the payment of principal, premium, if any, and
interest with respect to such debt securities to maturity or redemption, as the case may be. In addition, to exercise either of
our defeasance options, we must comply with certain other conditions, including the delivery to the trustee of an opinion of counsel
to the effect that the holders of debt securities of such series will not recognize income, gain or loss for Federal income tax
purposes as a result of such defeasance and will be subject to Federal income tax on the same amounts, in the same manner and
at the same times as would have been the case if such defeasance had not occurred (and, in the case of legal defeasance only,
such opinion of counsel must be based on a ruling from the Internal Revenue Service or other change in applicable Federal income
tax law).
The trustee will hold in trust the cash or
U.S. government obligations deposited with it as described above and will apply the deposited cash and the proceeds from deposited
U.S. government obligations to the payment of principal, premium, if any, and interest with respect to the debt securities of
the defeased series.
Mergers, Consolidations
and Certain Sales of Assets
We may not:
|
|
·
|
consolidate
with or merge into any other person or entity or permit any other person or entity to
consolidate with or merge into us in a transaction in which we are not the surviving
entity, or
|
|
|
·
|
transfer, lease
or dispose of all or substantially all of our assets to any other person or entity
|
unless:
|
|
·
|
the resulting,
surviving or transferee entity shall be a corporation organized and existing under the
laws of the United States or any state thereof and such resulting, surviving or transferee
entity shall expressly assume, by supplemental indenture, executed and delivered in form
satisfactory to the trustee, all of our obligations under the debt securities and the
indenture;
|
|
|
·
|
immediately
after giving effect to such transaction (and treating any indebtedness which becomes
an obligation of the resulting, surviving or transferee entity as a result of such transaction
as having been incurred by such entity at the time of such transaction), no default or
event of default would occur or be continuing; and
|
|
|
·
|
we shall have
delivered to the trustee an officers’ certificate and an opinion of counsel, each
stating that such consolidation, merger or transfer and such supplemental indenture (if
any) comply with the indenture.
|
Governing Law
The indenture and the debt securities will
be governed by the laws of the State of New York.
No Personal Liability
of Directors, Officers, Employees and Stockholders
No director, officer, incorporator or stockholder
of Energous, as such, shall have any liability for any obligations of Energous under the debt securities or the indenture or for
any claim based on, in respect of, or by reason of, such obligations or their creation, solely by reason of his, her, or its status
as director, officer, incorporator or stockholder of Energous. By accepting a debt security, each holder waives and releases all
such liability, but only such liability. The waiver and release are part of the consideration for issuance of the debt securities.
Nevertheless, such waiver may not be effective to waive liabilities under the federal securities laws and it has been the view
of the SEC that such a waiver is against public policy.
Conversion or Exchange
Rights
Any debt securities offered hereby may be convertible
into or exchangeable for shares of our equity or other securities. The terms and conditions of such conversion or exchange will
be set forth in the applicable prospectus supplement. Such terms may include, among others, the following:
|
|
·
|
the conversion
or exchange price;
|
|
|
·
|
the conversion
or exchange period;
|
|
|
·
|
provisions regarding
our ability or that of the holder to convert or exchange the debt securities;
|
|
|
·
|
events requiring
adjustment to the conversion or exchange price; and
|
|
|
·
|
provisions affecting
conversion or exchange in the event of our redemption of such debt securities.
|
Concerning the Trustee
The indenture provides that there may be more
than one trustee with respect to one or more series of debt securities. If there are different trustees for different series of
debt securities, each trustee will be a trustee of a trust under a supplemental indenture separate and apart from the trust administered
by any other trustee under such indenture. Except as otherwise indicated in this prospectus or any prospectus supplement, any
action permitted to be taken by a trustee may be taken by the trustee only with respect to the one or more series of debt securities
for which it is the trustee under an indenture. Any trustee under the indenture or a supplemental indenture may resign or be removed
with respect to one or more series of debt securities. All payments of principal of, premium, if any, and interest on, and all
registration, transfer, exchange authentication and delivery (including authentication and delivery on original issuance of the
debt securities) of, the debt securities of a series will be effected by the trustee with respect to such series at an office
designated by the trustee.
The indenture contains limitations on the right
of the trustee, should it become a creditor of Energous, to obtain payment of claims in certain cases or to realize on certain
property received in respect of any such claim as security or otherwise. If the trustee acquires an interest that conflicts with
any duties with respect to the debt securities, the trustee is required to either resign or eliminate such conflicting interest
to the extent and in the manner provided by the indenture.
Limitations on Issuance
of Bearer Debt Securities
Debt securities in bearer form are subject
to special U.S. tax requirements and may not be offered, sold, or delivered within the United States or its possessions or to
a U.S. person, except in certain transactions permitted by U.S. tax regulations. Investors should consult the relevant prospectus
supplement, in the event that bearer debt securities are issued for special procedures and restrictions that will apply to such
an offering.
DESCRIPTION
OF PREFERRED STOCK WE MAY OFFER
This section describes the general terms and
provisions of the preferred stock we may offer. This information may not be complete in all respects and is qualified entirely
by reference to our certificate of incorporation, with respect to each series of preferred stock. The specific terms of any series
will be described in a prospectus supplement. Those terms may differ from the terms discussed below. Any series of preferred stock
we issue will be governed by our certificate of incorporation and by the certificate of designations relating to that series.
We will file the certificate of designations with the SEC and incorporate it by reference as an exhibit to our registration statement
at or before the time we issue any preferred stock of that series.
Authorized Preferred
Stock
Our certificate of incorporation authorizes
us to issue 10,000,000 shares of preferred stock, par value $0.00001 per share. We may issue preferred stock from time to time
in one or more series, without shareholder approval, when authorized by our board of directors.
Upon issuance of a particular
series of preferred stock, our board of directors is authorized, to specify:
|
|
·
|
the
number of shares to be included in the series;
|
|
|
·
|
the
annual dividend rate for the series, if any, and any restrictions or conditions on the
payment of dividends;
|
|
|
·
|
the
redemption price, if any, and the terms and conditions of redemption;
|
|
|
·
|
any
sinking fund provisions for the purchase or redemption of the series;
|
|
|
·
|
if
the series is convertible, the terms and conditions of conversion;
|
|
|
·
|
the
amounts payable to holders upon our liquidation, dissolution or winding up; and
|
|
|
·
|
any
other rights, preferences and limitations relating to the series, including voting rights.
|
Our board of director’s ability to authorize,
without shareholder approval, the issuance of preferred stock with conversion and other rights, may adversely affect the rights
of holders of our common stock or other series of preferred stock that may be outstanding.
No shares of our preferred
stock are currently issued and outstanding.
Specific Terms of a Series
of Preferred Stock
The preferred stock we may offer will be issued
in one or more series. The preferred stock will have the dividend, liquidation, redemption and voting rights discussed below,
unless otherwise described in a prospectus supplement relating to a particular series. A prospectus supplement will discuss the
following features of the series of preferred stock to which it relates:
|
|
·
|
the designations
and stated value per share;
|
|
|
·
|
the
number of shares offered;
|
|
|
·
|
the
amount of liquidation preference per share;
|
|
|
·
|
the
public offering price at which the preferred stock will be issued;
|
|
|
·
|
the
dividend rate, the method of its calculation, the dates on which dividends would be paid
and the dates, if any, from which dividends would cumulate;
|
|
|
·
|
any
redemption or sinking fund provisions;
|
|
|
·
|
any
conversion or exchange rights; and
|
|
|
·
|
any
additional voting, dividend, liquidation, redemption, sinking fund and other rights,
preferences, privileges, limitations and restrictions.
|
Rank
Unless otherwise stated in the prospectus supplement,
the preferred stock will have priority over our common stock with respect to dividends and distribution of assets, but will rank
junior to all our outstanding indebtedness for borrowed money. Any series of preferred stock could rank senior, equal or junior
to our other capital stock, as may be specified in a prospectus supplement, as long as our certificate of incorporation so permits.
Dividends
Holders of each series of preferred stock shall
be entitled to receive cash dividends to the extent specified in the prospectus supplement when, as and if declared by our board
of directors, from funds legally available for the payment of dividends. The rates and dates of payment of dividends of each series
of preferred stock will be stated in the prospectus supplement. Dividends will be payable to the holders of record of preferred
stock as they appear on our books on the record dates fixed by our board of directors. Dividends on any series of preferred stock
may be cumulative or non-cumulative, as discussed in the applicable prospectus supplement.
Convertibility
Shares of a series of preferred stock may be
exchangeable or convertible into shares of our common stock, another series of preferred stock or other securities or property.
The conversion or exchange may be mandatory or optional. The prospectus supplement will specify whether the preferred stock being
offered has any conversion or exchange features, and will describe all the related terms and conditions.
Redemption
The terms, if any, on which shares of preferred
stock of a series may be redeemed will be discussed in the applicable prospectus supplement.
Liquidation
Upon any voluntary or involuntary liquidation,
dissolution or winding up of the affairs of Energous, holders of each series of preferred stock will be entitled to receive distributions
upon liquidation in the amount described in the related prospectus supplement. These distributions will be made before any distribution
is made on any securities ranking junior to the preferred stock with respect to liquidation, including our common stock. If the
liquidation amounts payable relating to the preferred stock of any series and any other securities ranking on a parity regarding
liquidation rights are not paid in full, the holders of the preferred stock of that series will share ratably in proportion to
the full liquidation preferences of each security. Holders of our preferred stock will not be entitled to any other amounts from
us after they have received their full liquidation preference.
Voting
The holders of preferred stock of each series
will have no voting rights, except as required by law and as described below or in a prospectus supplement. Our board of directors
may, upon issuance of a series of preferred stock, grant voting rights to the holders of that series to elect additional board
members if we fail to pay dividends in a timely fashion.
Without the affirmative vote of a majority
of the shares of preferred stock of any series then outstanding, we may not:
|
|
·
|
increase
or decrease the aggregate number of authorized shares of that series;
|
|
|
·
|
increase
or decrease the par value of the shares of that series; or
|
|
|
·
|
alter
or change the powers, preferences or special rights of the shares of that series so as
to affect them adversely.
|
No Other Rights
The shares of a series of preferred stock will
not have any preferences, voting powers or relative, participating, optional or other special rights except:
|
|
·
|
as
discussed above or in the prospectus supplement;
|
|
|
·
|
as
provided in our certificate of incorporation and in the certificate of designations;
and
|
|
|
·
|
as
otherwise required by law.
|
DESCRIPTION
OF COMMON STOCK WE MAY OFFER
The following summary description of our common
stock is based on the provisions of our certificate of incorporation or bylaws and the applicable provisions of the General Corporation
Law of the State of Delaware. This information may not be complete in all respects and is qualified entirely by reference to the
provisions of our certificate of incorporation, bylaws and the General Corporation Law of the State of Delaware. For information
on how to obtain copies of our certificate of incorporation and bylaws, see the discussion above under the heading “Where
You Can Find More Information.”
We may offer our common stock issuable upon
the conversion of debt securities or preferred stock and the exercise of warrants.
Authorized Capital
We currently have authority to issue 50,000,000
shares of our common stock, par value $0.00001 per share. As of April 10, 2015, 12,888,243 shares of our common stock were issued
and outstanding. Our authorized but unissued shares of common stock are available for issuance without further action by our stockholders,
unless such action is required by applicable law or the rules of any stock exchange or automated quotation system on which our
securities may be listed or traded.
Voting Rights
Each outstanding share of our common stock
is entitled to one vote on all matters submitted to a vote of shareholders. There is no cumulative voting.
Dividend and Liquidation
Rights
The holders of outstanding shares of our common
stock are entitled to receive dividends out of assets legally available for the payment of dividends at the times and in the amounts
as our board of directors may from time to time determine. The shares of our common stock are neither redeemable nor convertible.
Holders of our common stock have no preemptive or subscription rights to purchase any securities of Energous. Upon the liquidation,
dissolution or winding up of Energous, the holders of our common stock are entitled to receive pro rata the assets of Energous
which are legally available for distribution, after payment of all debts and other liabilities and subject to the prior rights
of any holders of preferred stock then outstanding.
We have never paid any cash dividends on our
common stock.
DESCRIPTION
OF WARRANTS WE MAY OFFER
We may issue warrants for the purchase of debt
securities, preferred stock or common stock. Warrants may be issued independently or together with debt securities, preferred
stock or common stock and may be attached to or separate from any offered securities. Any issue of warrants will be governed by
the terms of the applicable form of warrant and any related warrant agreement which we will file as an exhibit to our registration
statement at or before the time we issue any warrants.
The particular terms of any issue of warrants
will be described in the prospectus supplement relating to the issue. Those terms may include:
|
|
·
|
the
title of such warrants;
|
|
|
·
|
the
aggregate number of such warrants;
|
|
|
·
|
the
price or prices at which such warrants will be issued;
|
|
|
·
|
the
currency or currencies (including composite currencies) in which the price of such warrants
may be payable;
|
|
|
·
|
the
terms of the securities purchasable upon exercise of such warrants and the procedures
and conditions relating to the exercise of such warrants;
|
|
|
·
|
the
price at which the securities purchasable upon exercise of such warrants may be purchased;
|
|
|
·
|
the
date on which the right to exercise such warrants will commence and the date on which
such right shall expire;
|
|
|
·
|
any
provisions for adjustment of the number or amount of securities receivable upon exercise
of the warrants or the exercise price of the warrants;
|
|
|
·
|
if
applicable, the minimum or maximum amount of such warrants that may be exercised at any
one time;
|
|
|
·
|
if
applicable, the designation and terms of the securities with which such warrants are
issued and the number of such warrants issued with each such security;
|
|
|
·
|
if
applicable, the date on and after which such warrants and the related securities will
be separately transferable;
|
|
|
·
|
information
with respect to book-entry procedures, if any; and
|
|
|
·
|
any
other terms of such warrants, including terms, procedures and limitations relating to
the exchange or exercise of such warrants.
|
The prospectus supplement relating to any warrants
to purchase equity securities may also include, if applicable, a discussion of certain U.S. federal income tax and ERISA considerations.
Warrants for the purchase of preferred stock
and common stock will be offered and exercisable for U.S. dollars only.
Each warrant will entitle its holder to purchase
the principal amount of debt securities or the number of shares of preferred stock or common stock at the exercise price set forth
in, or calculable as set forth in, the applicable prospectus supplement.
After the close of business on the expiration
date, unexercised warrants will become void. We will specify the place or places where, and the manner in which, warrants may
be exercised in the applicable prospectus supplement.
Prior to the exercise of any warrants to purchase
debt securities, preferred stock or common stock, holders of the warrants will not have any of the rights of holders of the debt
securities, preferred stock or common stock purchasable upon exercise.
ANTI-TAKEOVER
EFFECTS OF CERTAIN PROVISIONS OF DELAWARE LAW
AND OUR CHARTER DOCUMENTS
The following is a summary of certain provisions
of Delaware law, our Certificate of Incorporation and our bylaws. This summary does not purport to be complete and is qualified
in its entirety by reference to the corporate law of Delaware and our Certificate of Incorporation and bylaws.
Effect of Delaware Anti-Takeover Statute.
We are subject to Section 203 of the Delaware General Corporation Law, an anti-takeover law. In general, Section 203 prohibits
a Delaware corporation from engaging in any business combination (as defined below) with any interested stockholder (as defined
below) for a period of three years following the date that the stockholder became an interested stockholder, unless:
·
prior
to that date, the board of directors of the corporation approved either the business combination or the transaction that resulted
in the stockholder becoming an interested stockholder;
·
upon
consummation of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder
owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes
of determining the number of shares of voting stock outstanding (but not the voting stock owned by the interested stockholder)
those shares owned by persons who are directors and officers and by excluding employee stock plans in which employee participants
do not have the right to determine whether shares held subject to the plan will be tendered in a tender or exchange offer; or
·
on
or subsequent to that date, the business combination is approved by the board of directors of the corporation and authorized at
an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding
voting stock that is not owned by the interested stockholder.
Section 203 defines “business combination”
to include the following:
·
any
merger or consolidation involving the corporation and the interested stockholder;
·
any
sale, transfer, pledge or other disposition of 10% or more of the assets of the corporation involving the interested stockholder;
·
subject
to certain exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation
to the interested stockholder;
·
subject
to limited exceptions, any transaction involving the corporation that has the effect of increasing the proportionate share of
the stock of any class or series of the corporation beneficially owned by the interested stockholder; or
·
the
receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits provided
by or through the corporation.
In general, Section 203 defines an interested
stockholder as any entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation, or who
beneficially owns 15% or more of the outstanding voting stock of the corporation at any time within a three-year period immediately
prior to the date of determining whether such person is an interested stockholder, and any entity or person affiliated with or
controlling or controlled by any of these entities or persons.
Effect of California Corporation Long-Arm
Statute
. We are a Delaware corporation, governed by the Delaware General Corporation Law; however, our headquarters, property
and officers are located in California. Section 2115 of the California Corporations Code (the “California Corporation Long-Arm
Statute”) purports to impose on corporations like the Company certain portions of California’s laws governing corporations
formed under the laws of the State of California. While disputes have arisen regarding the enforceability of the California Corporation
Long-Arm Statute, the statute purports to apply the California Corporations Code in the following areas of governance to corporations
that meet the test for applicability for the California Corporation Long-Arm Statute: Chapter 1 (general provisions and definitions),
to the extent applicable to the following provisions; Section 301 (annual election of directors); Section 303 (removal of directors
without cause); Section 304 (removal of directors by court proceedings); Section 305, subdivision (c) (filling of director vacancies
where less than a majority in office elected by shareholders); Section 309 (directors’ standard of care); Section 316 (excluding
paragraph (3) of subdivision (a) and paragraph (3) of subdivision (f)) (liability of directors for unlawful distributions); Section
317 (indemnification of directors, officers, and others); Sections 500 to 505, inclusive (limitations on corporate distributions
in cash or property); Section 506 (liability of shareholder who receives unlawful distribution); Section 600, subdivisions (b)
and (c) (requirement for annual shareholders’ meeting and remedy if same not timely held); Section 708, subdivisions (a),
(b), and (c) (shareholder’s right to cumulate votes at any election of directors); Section 710 (supermajority vote requirement);
Section 1001, subdivision (d) (limitations on sale of assets); Section 1101 (provisions following subdivision (e)) (limitations
on mergers); Section 1151 (first sentence only) (limitations on conversions); Section 1152 (requirements of conversions); Chapter
12 (commencing with Section 1200) (reorganizations); Chapter 13 (commencing with Section 1300) (dissenters’ rights); Sections
1500 and 1501 (records and reports); Section 1508 (action by Attorney General); Chapter 16 (commencing with Section 1600) (rights
of inspection).
We believe it is likely that we meet the test
for the application of the California Corporation Long-Arm Statute and do not anticipate a specific time in the future when we
would not meet such test. The California Corporation Long-Arm Statute, if applicable, would purport to require a different outcome
for certain important activities fundamental to the governance of corporations, and you are encouraged to review the effect of
the California Long-Arm Statute to determine whether the differences from the Delaware General Corporation Law are important to
you.
Our Charter Documents
. Our charter documents
include provisions that may have the effect of discouraging, delaying or preventing a change in control or an unsolicited acquisition
proposal that a stockholder might consider favorable, including a proposal that might result in the payment of a premium over
the market price for the shares held by our stockholders. Certain of these provisions are summarized in the following paragraphs.
Effects of authorized but unissued common
stock.
One of the effects of the existence of authorized but unissued common stock may be to enable our board of directors
to make more difficult or to discourage an attempt to obtain control of our Company by means of a merger, tender offer, proxy
contest or otherwise, and thereby to protect the continuity of management. If, in the due exercise of its fiduciary obligations,
the board of directors were to determine that a takeover proposal was not in our best interest, such shares could be issued by
the board of directors without stockholder approval in one or more transactions that might prevent or render more difficult or
costly the completion of the takeover transaction by diluting the voting or other rights of the proposed acquirer or insurgent
stockholder group, by putting a substantial voting block in institutional or other hands that might undertake to support the position
of the incumbent board of directors, by effecting an acquisition that might complicate or preclude the takeover, or otherwise.
Cumulative Voting
. Our Certificate of
Incorporation does not provide for cumulative voting in the election of directors, which would allow holders of less than a majority
of the stock to elect some directors.
Vacancies.
Our Certificate of Incorporation
provides that all vacancies may be filled by the affirmative vote of a majority of directors then in office, even if less than
a quorum.
Special Meeting of Stockholders.
A special
meeting of stockholders may only be called by the President, the Chief Executive Officer, or the board of directors at any time
and for any purpose or purposes as shall be stated in the notice of the meeting, or by request of the holders of record of at
least 10% of the outstanding shares of common stock. This provision could prevent stockholders from calling a special meeting
because, unless certain significant stockholders were to join with them, they might not obtain the percentage necessary to request
the meeting. Therefore, stockholders holding less than 10% of the issued and outstanding common stock, without the assistance
of management, may be unable to propose a vote on any transaction that would delay, defer or prevent a change of control, even
if the transaction were in the best interests of our stockholders.
PLAN
OF DISTRIBUTION
We may sell the securities offered by this
prospectus to one or more underwriters or dealers for public offering, through agents, directly to purchasers or through a combination
of any such methods of sale. The name of any such underwriters, dealers or agents involved in the offer and sale of the
securities, the amounts underwritten and the nature of its obligation to take the securities will be specified in the applicable
prospectus supplement. We have reserved the right to sell the securities directly to investors on our own behalf in those
jurisdictions where we are authorized to do so. The sale of the securities may be effected in transactions (a) on any national
or international securities exchange or quotation service on which the securities may be listed or quoted at the time of sale,
(b) in the over-the-counter market, (c) in transactions otherwise than on such exchanges or in the over-the-counter market or
(d) through the writing of options.
We and our agents and underwriters, may offer
and sell the securities at a fixed price or prices that may be changed, at market prices prevailing at the time of sale, at prices
related to such prevailing market prices or at negotiated prices. The securities may be offered on an exchange, which will
be disclosed in the applicable prospectus supplement. We may, from time to time, authorize dealers, acting as our agents,
to offer and sell the securities upon such terms and conditions as set forth in the applicable prospectus supplement.
If we use underwriters to sell securities,
we will enter into an underwriting agreement with them at the time of the sale to them. In connection with the sale of the
securities, underwriters may receive compensation from us in the form of underwriting discounts or commissions and may also receive
commissions from purchasers of the securities for whom they may act as agent. Any underwriting compensation paid by us to
underwriters or agents in connection with the offering of the securities, and any discounts, concessions or commissions allowed
by underwriters to participating dealers, will be set forth in the applicable prospectus supplement to the extent required by
applicable law. Underwriters may sell the securities to or through dealers, and such dealers may receive compensation in
the form of discounts, concessions or commissions from the underwriters or commissions (which may be changed from time to time)
from the purchasers for whom they may act as agents.
Dealers and agents participating in the distribution
of the securities may be deemed to be underwriters, and any discounts and commissions received by them and any profit realized
by them on resale of the securities may be deemed to be underwriting discounts and commissions under the Securities Act. Unless
otherwise indicated in the applicable prospectus supplement, an agent will be acting on a best efforts basis and a dealer will
purchase debt securities as a principal, and may then resell the debt securities at varying prices to be determined by the dealer.
If so indicated in the prospectus supplement,
we will authorize underwriters, dealers or agents to solicit offers by certain specified institutions to purchase offered securities
from us at the public offering price set forth in the prospectus supplement pursuant to delayed delivery contracts providing for
payment and delivery on a specified date in the future. Such contracts will be subject to any conditions set forth in the
applicable prospectus supplement and the prospectus supplement will set forth the commission payable for solicitation of such
contracts. The underwriters and other persons soliciting such contracts will have no responsibility for the validity or
performance of any such contracts.
Underwriters, dealers and agents may be entitled,
under agreements entered into with us, to indemnification against and contribution towards certain civil liabilities, including
any liabilities under the Securities Act.
To facilitate the offering of securities, certain
persons participating in the offering may engage in transactions that stabilize, maintain, or otherwise affect the price of the
securities. These may include over-allotment, stabilization, syndicate short covering transactions and penalty bids. Over-allotment
involves sales in excess of the offering size, which creates a short position. Stabilizing transactions involve bids to
purchase the underlying security so long as the stabilizing bids do not exceed a specified maximum. Syndicate short covering
transactions involve purchases of securities in the open market after the distribution has been completed in order to cover syndicate
short positions. Penalty bids permit the underwriters to reclaim selling concessions from dealers when the securities originally
sold by the dealers are purchased in covering transactions to cover syndicate short positions. These transactions may cause
the price of the securities sold in an offering to be higher than it would otherwise be. These transactions, if commenced,
may be discontinued by the underwriters at any time.
Any securities other than our common stock
issued hereunder may be new issues of securities with no established trading market. Any underwriters or agents to or through
whom such securities are sold for public offering and sale may make a market in such securities, but such underwriters or agents
will not be obligated to do so and may discontinue any market making at any time without notice. No assurance can be given
as to the liquidity of the trading market for any such securities. The amount of expenses expected to be incurred by us
in connection with any issuance of securities will be set forth in the applicable prospectus supplement. Certain of the
underwriters, dealers or agents and their associates may engage in transactions with, and perform services for, us and certain
of our affiliates in the ordinary course of business.
During such time as we may be engaged in a
distribution of the securities covered by this prospectus we are required to comply with Regulation M promulgated under the Exchange
Act. With certain exceptions, Regulation M precludes us, any affiliated purchasers, and any broker-dealer or other person
who participates in such distribution from bidding for or purchasing, or attempting to induce any person to bid for or purchase,
any security which is the subject of the distribution until the entire distribution is complete. Regulation M also restricts
bids or purchases made in order to stabilize the price of a security in connection with the distribution of that security. All
of the foregoing may affect the marketability of our shares of common stock.
LEGAL
MATTERS
The validity and legality of the securities
offered hereby and certain other legal matters will be passed upon for the Company by K&L Gates LLP, Charlotte, North Carolina
28202.
EXPERTS
The financial statements of Energous Corporation
as of December 31, 2014 and 2013 and for the years ended December 31, 2014 and 2013 included in this prospectus have been audited
by Marcum LLP, independent registered public accounting firm, as set forth in their report. We have included these financial statements
in this prospectus in reliance upon the report of Marcum LLP, given on their authority as experts in accounting and auditing.
Up to
$40,000,000
ENERGOUS CORPORATION
Common
Stock
Prospectus
Supplement
RAYMOND JAMES
January 12, 2018
Energous (NASDAQ:WATT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Energous (NASDAQ:WATT)
Historical Stock Chart
From Apr 2023 to Apr 2024
